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Abstract
Because endometriosis is considered to be the primary cause of infertility in women and
the diagnosis is known to be delayed by many years, it is important to understand the
association between endometriosis and infertility. The purpose of this cross-sectional,
secondary data analysis study was to determine whether there was an association between
the age of women when diagnosed with endometriosis and infertility. Using the general
model of total patient delay (i.e., the Andersen model) as a theoretical foundation, data
for this study was collected by assessing patient medical records of women with
endometriosis at multiple OB-GYN clinics in Eastern North Carolina. Multiple logistic
regression was conducted to determine potential association between variables. The
results presented that diagnosis at an older age and presence of uterine fibroids are
significant risk factors for infertility among women with endometriosis. From the results,
it can be concluded that infertility may be preventable in women diagnosed with
endometriosis and uterine fibroids in younger age. This study presents positive social
change by preventing infertility amongst women who suffer from both endometriosis and
uterine fibroids; potentially creating preventative programs aimed at better educating
women on the risks of endometriosis and uterine fibroids (especially when presented
together).
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Chapter 1: Introduction to the Study
Introduction
A diagnosis of endometriosis has been found to be delayed anywhere from 7-10
years and is often not recognized by physicians in practice, leading to misdiagnosis
and/or suboptimal care (Johnston, Reid, & Hunter, 2015). Investigation concerning
causes of female infertility is receiving less attention; although, there are optimal
approaches to managing infertility that require a method associated with routine and
timely measures (Bell, 2014). Earlier diagnosis of the disease (e.g., diagnosis at an earlier
age) could serve as a preventative strategy towards infertility. If a statistically significant
association between age of women when diagnosed with endometriosis and infertility is
determined, beliefs that suppressive medical treatment does not benefit fertility
(American Society for Reproductive Medicine, 2012) could be proven false, which could
lead to fewer incidences of endometriosis-related infertility. Furthermore, determining a
statistically significant association also could provide for more effective patient/doctor
visits for women who suffer from common symptoms of endometriosis.
Although suppressive medical treatment of endometriosis does not benefit
fertility, the age of a woman when diagnosed with endometriosis has not been taken into
consideration (American Society for Reproductive Medicine, 2012). Determining
diagnosis at an earlier age can serve as a preventative strategy against infertility. In this
study, I contributed to the literature on women’s health by determining whether age of
women, when diagnosed with endometriosis, is associated with higher and lower
incidences of infertility.
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The findings of the study might lead to social change by adding new evidence to a
topic within women’s health that has been considered a controversial topic (Kovacs,
2015). The findings of the study are expected to provide information on existing
information and theories about the disease that are false/misleading. The study is may
provide information that may help individuals recognize and understand normal
menstrual cycles versus abnormal menstrual cycles, as well as normal symptoms
associated with menstrual cycles versus abnormal pain that can be linked to
endometriosis. The study may also provide physicians with more information about
prompt endometriosis diagnoses. Furthermore, the study may provide support for women
who suffer from the disease. Women should be made aware that effective treatment is
available if they seek it. Last, the study is expected to promote social change by further
highlighting the effects of endometriosis that affect women and their families because the
disease currently is not recognized as a medical disability (Jones, 2016).
Endometriosis may go undiagnosed for anywhere from 7-10 years, and
endometriosis is associated with infertility (Johnston, Reid, & Hunter, 2015). Because
there currently are no existing studies on the potential association between the age of
women when diagnosed with the disease and infertility, the results of this study might aid
in the development of better precautionary methods for avoiding infertility while living
with endometriosis.
Background
Suppressive medical treatment of endometriosis does not increase fertility; yet,
the age of women when diagnosed with the disease never has been taken into
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consideration when assessing infertility rates amongst women diagnosed with the disease
(American Society for Reproductive Medicine, 2012; Radhika, Chawla, Nanda, Yadav,
& Radhakrishnan, 2016). Radhika et al. (2016) found that 73% of patients had moderate
to severe endometriosis (age groups: <20, 21-30, >30 – with average age of participants
being 29.6 years) with 31.46% of the participants classified as being infertile.
Furthermore, correlations between stages and infertility per age have never been
examined (Radhika et al., 2016). This study was needed in order to increase the
understanding the association between endometriosis and infertility, especially in regards
to how the age in which a woman is diagnosed with the disease might affect her ability to
conceive.
Scholars have examined the process associated with diagnosing endometriosis,
the sites inside a woman’s body where endometriosis can occur, the impact endometriosis
has on the lives of women and their families, the treatment for endometriosis, the
potential link between endometriosis and infertility, and the potential impact uterine
fibroids may have on women diagnosed with endometriosis. Although pregnancy rates
for patients with endometriosis range from 24%-54%, estimated rates may be
overestimated (Burghaus et al., 2016). Overlapping symptoms commonly associated with
endometriosis should alert physicians to seek measures that aid in the formal diagnosis of
the disease (Fauconnier et al., 2013). Furthermore, endometriosis poses detrimental
impacts on women’s lives due to negative effects on marital/sexual relationships, social
life, and physical and psychological wellbeing (Moradi, Parker, Sneddon, Lopez, &
Ellwood, 2014). Patients who suffer from endometriosis might also suffer from uterine
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fibroids, potentially increasing their chances of infertility (Uimari, Jarvela, & Ryynamen,
2011).
The purpose of this study was to determine whether there was an association
between the age of a woman upon diagnosis of the disease and infertility. Earlier
diagnosis of the disease (e.g. diagnosis at an earlier age) could serve as a preventative
strategy towards infertility. If a statistically significant association between age of women
when diagnosed with endometriosis and infertility is determined, there could be fewer
incidences of endometriosis-related infertility. Furthermore, determining a statistically
significant association also could provide for more effective patient/doctor visits for
women who suffer from common symptoms of endometriosis.
Problem Statement
Endometriosis is the primary cause of infertility in the United States, having a
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women (Juneau
Biosciences, 2016). The management of endometriosis-associated infertility, however, is
unknown (Dunselman et al., 2014). There is a connection between infertility and
endometriosis; however, the association between the two still remains uncertain
(American Society for Reproductive Medicine, 2012). The longer that endometriosis goes
undiagnosed, the more damage it can do; yet, there are few early diagnoses of the disease
because many physicians are unaware of the common symptoms associated with the
disease (Levett, 2016). Some patients have claimed that they visit their doctor with
symptoms of lower abdominal and pelvic pain (common symptoms of endometriosis)
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only to receive no support from physicians aside from receiving a prescription for opioids
(i.e., painkillers; Johnston et al., 2015).
Diagnosis of endometriosis among women has been found to be delayed
anywhere from 7-10 years and is poorly recognized by physicians in practice, leading to
misdiagnosis and/or suboptimal care (Johnston et al., 2015). Investigation concerning
causes of female infertility is receiving less attention; although, there are optimal
approaches to managing infertility that require a method associated with routine and
timely measures (Bell, 2014). Earlier diagnosis of the disease (e.g., diagnosis at an earlier
age) could serve as a preventative strategy towards infertility. If a statistically significant
association between age of women when diagnosed with endometriosis and infertility is
determined, beliefs that suppressive medical treatment does not benefit fertility
(American Society for Reproductive Medicine, 2012) could be proven false, which could
lead to fewer incidences of endometriosis-related infertility. Furthermore, determining a
statistically significant association also could provide for more effective patient/doctor
visits for women who suffer from common symptoms of endometriosis.
Purpose of Study
The purpose of the study was to determine whether an association exists between
the time in which a woman is diagnosed with endometriosis (i.e., age of woman when
diagnosed) and infertility. To address this gap, I used a quantitative research method. I
assessed a potential association between variables to address the lack of knowledge that
exists in regards to the association between endometriosis and infertility and how the age
in which a woman is diagnosed with the disease might affect her ability to conceive. The
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independent variable for this study was age, which described the age in which a woman
was formally diagnosed with endometriosis. The dependent variable for this study
consisted of infertility, which described whether or not a woman was considered to be
unable to conceive. The variables site/implantation and uterine fibroids also were used as
potential confounders affecting the association between age upon diagnosis of
endometriosis and infertility.
Research Questions and Hypotheses
RQ1: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for history of uterine fibroids?
(H01): There is no statistically significant association between infertility and age
of women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
(H11): There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
RQ2: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for the specific sites of endometriosis?
(H02): There is no statistically significant association between infertility and age
of women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
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(H12): There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
Theoretical Foundation
The theoretical framework for this study consisted of the general model of total
patient delay, also known as the Andersen model, which is used for a variety of disorders
(Walter, Webster, Scott, & Emery, 2012). The Andersen model was developed by
Andersen in 1968 (Andersen & Newman, 1973). Reducing diagnostic delays may result
in improved prognosis for most disorders (Walter et al., 2012). The Andersen model is
used to explain aspects regarding delay stages (e.g., appraisal, illness, behavioral,
scheduling, treatment) and was used in this study as a means to test whether diagnosis of
endometriosis might pose a higher incidence for risk (i.e., infertility) based on age. The
model also aided in explaining why certain time intervals exist between onset of
symptoms of endometriosis and formal diagnosis. According to the Anderson model,
diagnostic delay results from conceptual beliefs about a person’s symptoms; behavioral
factors, such as strategies for self-appraisal; and techniques for coping with illness and
emotional reaction (Walter et al., 2012). Such topics will be explained in further detail in
Chapter 2.
Nature of Study
I used the quantitative approach in this study. Quantitative research was
appropriate in determining whether there was a statistically significant association
between age of women when diagnosed with endometriosis and infertility, as descriptive
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quantitative researchers establish associations between variables (Creswell, 2013).
Furthermore, because uterine fibroids and endometriosis may be associated with each
other, the history of uterine fibroids may have an association with the age of women
when diagnosed with endometriosis and infertility (Nezhat et al., 2016; Uimari et al.,
2011). I used a cross-sectional design with the use of secondary data analysis of existing
medical records. In regard to statistical methods, I used multiple logistic regression and
crosstabulation to assess potential association between variables. Age acted as the
independent variable, and infertility acted as the dependent variable.
Definitions
Age: The number of years from birth of the respondent to the date when she was
formally diagnosed with endometriosis.
Endometriosis: The presence of endometrial glands or stroma in sites other than
the uterine cavity (Jacobson et al., 2016).
Formal diagnosis: Endometriosis confirmed by laparoscopic procedure.
Infertility: Failure to achieve a successful pregnancy after 12 months or more of
regular, unprotected sexual intercourse (Mascarenhas, Cheung, Mathers, & Stevens,
2012).
History of uterine fibroids: Having documentation by a physician concerning the
presence of uterine fibroids on the uterus.
Laparoscopic procedure: Minimal invasive surgery where a slender viewing
instrument (laparoscope) is inserted through a small incision near the naval for diagnosis
and/or removing endometrial tissue through another small incision (Mayo Clinic, 2016).
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Site and location of endometriosis: The part of the female anatomy where the
endometriosis is implanted; it is important for explaining its potential side effects
(Barcellos, Lasmar, & Lasmar, 2016).
Stage I or minimal endometriosis: Few isolated endometrial implants outside the
uterus; there is minimal number of mild adhesions in one area, if any (Mashayekhi et al.,
2017).
Stage II or mild endometriosis: Few isolated, slightly deeper endometrial implants
outside the uterus; there is minimal number of mild adhesions in one area (Mashayekhi et
al., 2017)
Assumptions
There were several assumptions that were assumed in this study. First, it was
assumed that the diagnostic laparoscopic procedures performed on each of the women
whose charts were assessed for this study were well performed and preceded by
appropriate preoperative assessment. For example, it was assumed that each of the
women’s diagnostic laparoscopic procedures were followed by biopsies in order to obtain
histological confirmation of the diagnosis. Second, it was assumed that all women whose
charts were assessed for this study underwent laparoscopic procedure strictly for the
reason to either confirm or deny the presence of endometriosis. Third, it was assumed
that all women whose charts were assessed for this study did not seek any type of fertility
treatment (e.g., fertility drugs, in vitro fertilization (IVF), intrauterine insemination (IUI),
etc.) aside from the removal of endometriosis via laparoscopic procedure. The fourth and
final assumption was that all women whose charts were assessed for this study wished to
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conceive. Such assumptions were necessary in the context of the study given that poorly
performed laparoscopic procedures not followed by biopsies can be less informative and
of limited value (Dunselman et al., 2014). Furthermore, if women chose to undergo
laparoscopic procedure for other reasons, such as having a history of pelvic infection,
conclusions to be made from study results given the variables could be flawed. Last, if
any of the women whose charts were assessed underwent any type of fertility treatment
aside from the removal of endometriosis via laparoscopic procedure, bias could be
introduced to the study results.
Scope and Delimitations
The delimitations of this study were age and being a patient at any OBGYN/fertility clinic located in Eastern North Carolina. Given the geographical scope of
the study, it is possible that the data were not representative of women living in other
parts of North Carolina, and it also was possible that the data were not representative of
other age groups outside from the ones assessed in this study (i.e., age 18-35). This study
included data from medical charts of women of all races/ethnicities who were considered
to be of reproductive age. Given that not just one particular race/ethnicity was
considered, the study results do not favor one race/ethnicity over another. In order to
meet the inclusion criteria, patients had to be in the age range of 18-35 years, as such age
group is considered to be within good standards in regard to reproduction, with women’s
fertility decreasing substantially by their late 30s (Lezzoni et al., 2014). Furthermore,
only patients diagnosed with Stage I (or minimal) or Stage II (or mild) were
endometriosis used for this study. I did not include data on women who were over the age
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of 35, as I wanted to avoid the factor of age as a possibility for infertility, alone. Also, I
did not include data on women who possessed multiple locations of deep adhesions or
implants (i.e., implants/adhesions involving multiple organs), as I wanted to accurately
compare how site/location of endometrioma might affect the association between
infertility and the age in which a woman is diagnosed with endometriosis separately.
The scope of this study was aided by the Andersen model, as this model has been
used for a variety of disorders to explain aspects regarding delay stages of disease (e.g.,
appraisal, illness, behavioral, scheduling, and treatment; Walter et al., 2012). I used the
Andersen model to determine whether diagnosis of endometriosis potentially poses a
higher incidence for risk (i.e., infertility) based on age. The model also aided in furthering
an explanation of why certain time intervals exist between onset of symptoms of
endometriosis and formal diagnosis. The feminist standpoint theory (FST) also was
considered for this study, but was found to be inappropriate given that many of its claims
are argued by researchers and also given that its fundamental structure focuses on
epistemologies of ignorance among male physicians towards female patients (ReidHresko & Goldman, 2016), which would not guide the research questions for this study.
I decided to study existing medical charts of women who were considered to be of
good reproductive age (e.g. age 18-35 years) because women of such age groups are
expected to be able to successfully conceive, especially without any given reproductive
disease (Reid-Hresko & Goldman, 2016). I decided not to exclude the assessment of
patients’ medical charts based on certain races/ethnicities because I did not wish to
consider any potential racial disparities in regard to endometriosis given that similar rates
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of the disease are observed among women of different races (Gerlinger, Faustmann,
Hassall, & Seitz, 2012).
Limitations
This study contained several limitations. The first limitation was the I only used a
secondary analysis of existing data. The data were not originally collected in order to
address the particular research question or to test the particular research hypotheses,
which is a limitation to a study (Cheng & Phillips, 2014). Another limitation included the
conducting of a secondary analysis of existing data, as I was not involved in the data
collection process; therefore, I was unaware of any nuances in the data collection process
that might be important to the interpretation of the key variables (Cheng & Phillips,
2014). A third limitation related to race/ethnicity. I did not assess race or ethnicity among
women whose medical charts were assessed. The association between the age in which a
woman is diagnosed with endometriosis and infertility might differ when the factor of
race is considered; even though endometriosis rates are considered to be similar among
races (Gerlinger et al., 2012). A fourth limitation related to the marital status of women. I
did not take into consideration the marital status of the women whose medical charts
were assessed. Such sociodemographic variable could influence fertility status given that
married couples are considered to be more likely to try to conceive than unmarried
couples (Laplante & Fostik, 2015).
Significance
Although suppressive medical treatment for endometriosis does not improve
fertility, the age of a woman when diagnosed with endometriosis has not been taken into
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consideration (American Society for Reproductive Medicine, 2012) prior to this study.
Diagnosis at an earlier age can serve as a preventative strategy against infertility.
Therefore, the purpose of this study was to determine if there was a statistically
significant association between the age of a woman when diagnosed with the disease and
infertility. The relationship between the two is not understood (Dunselman et al., 2014).
Because there are no studies on the potential association between the age of women when
diagnosed with the disease and infertility, the outcomes from the study might aid in the
development of better precautionary methods for avoiding infertility while living with
endometriosis.
The findings of the study are expected to provide information on theories about
the disease that perhaps are false/misleading, as well as serve as an asset for supplying
readers with knowledge regarding the topic; which ultimately should better help
individuals recognize and understand “normal” menstrual cycles versus abnormal
menstrual cycles, as well as “normal” symptoms associated with menstrual cycles versus
serious abnormal pain that can be linked to endometriosis. Again, the study also is
expected to serve as evidence for why confirming endometriosis diagnoses carefully and
more promptly should be of higher concern to physicians. Furthermore, in regard to
social change, the study hopefully will be able to provide a sense of support for women
who suffer from the disease, inspiring them not to overlook health emergencies out of
fear or frustration that there is no hope and/or relief exists. Women should be made
aware that effective treatment is available if they seek it. All in all, the study is expected
to promote social change by further supporting the devastating effects of endometriosis
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that burden women and their families since the disease currently is not recognized as a
medical disability (Jones, 2016).
Summary
Although endometriosis has been well-documented in medical texts for more than
4,000 years and was formally discovered microscopically by von Rokitansky in 1860
(Nezhat, Nezhat, & Nezhat, 2012), the disease still remains the subject of debate,
especially over the last decade (Brosens & Benagiano, 2011). Furthermore, although
laparoscopic procedure was introduced in the early 1960s, which can be used to
distinguish between three different clinical presentations of endometriosis (i.e.,
peritoneal, deep adenomyotic, and cystic ovarian; Brosens & Benagiano, 2011), diagnosis
of endometriosis is delayed anywhere from 7-10 years and is poorly recognized by
physicians in practice, often leading to misdiagnosis and/or suboptimal care (Johnston et
al., 2015).
In this chapter, the background of endometriosis was explained, along with its
association to infertility. Introduction to the research literature regarding the topic was
provided. The purpose of the study was established. In addition, the research questions
and hypotheses, the nature of the study, important terms/definitions, assumptions, scope
and delimitations, limitations, and significance of the study were discussed.
In Chapter 2, a detailed review of the literature is provided. In Chapter 2, I
summarize a range of topics related to endometriosis: endometriosis as a disease, the
impact of endometriosis on women’s lives, the different sites/locations endometriosis can
occur, treatment for endometriosis, the association between endometriosis and infertility,
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and the presence of uterine fibroids among patients diagnosed with endometriosis. The
theoretical framework is further discussed as well, along with implications for the use of
a secondary data analysis in the form of patients’ medical records.
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Chapter 2: Literature Review
Introduction
Considered to be the primary cause of infertility in the United States, with a
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women, endometriosis
diagnosis is delayed among women anywhere from 7-10 years and is poorly recognized
by physicians in practice (Juneau Biosciences, 2016; Johnston et al., 2015).
Endometriosis often is misdiagnosed and many women receive suboptimal care (Johnston
et al., 2015). The optimal choice of management for endometriosis-associated infertility
is unknown (Dunselman et al., 2014). Although infertility and endometriosis are
connected, the association between endometriosis and infertility still remains uncertain
(American Society for Reproductive Medicine, 2012). The longer endometriosis goes
undiagnosed, the more damaging it can be to women’s bodies; physicians often times
misdiagnose common symptoms linked to endometriosis (Levett, 2016). For example,
many patients claim to have a long history of doctor visits due to lower abdominal and
pelvic pain only to receive no support from physicians aside from receiving a prescription
for painkillers (Johnston et al., 2015).
Because the causes of female infertility is receiving less attention in the literature
(Bell, 2014), the purpose of this study was to determine whether there was an association
between the time in which a woman is diagnosed with endometriosis (i.e., age of woman
when diagnosed) and infertility. The results of this study can may lead to improved
understanding of the association between endometriosis and infertility, specifically in
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regards to how the age in which a woman is diagnosed with the disease might affect her
ability to conceive.
Because endometriosis is an estrogen-dependent condition characterized by
endometrial glands and stroma located outside the uterine cavity (Bruggmann et al.,
2016), sites where endometriosis can implant will be discussed. Furthermore, I will
discuss how endometriosis can affect not only the woman suffering from the disease, but
also those around her, such as a partner or spouse (Moradi et al., 2014). Although there is
no cure for endometriosis (Endometriosis Association, 2016), treatment options available
for women who suffer from the disease will be discussed. I will examine how
endometriosis is considered to be the primary cause of infertility in the United States, and
I will discuss the association between endometriosis and infertility. Last, I will explore
how presence of uterine fibroids in women with endometriosis.
Literature Search Strategy
The literature was searched using the following databases: MEDLINE, CINAHL,
EBSCO, PubMed, and Science Direct. Keywords used to search the literature included
endometriosis, endometriosis AND quality of life, endometriosis AND work productivity,
endometriosis location, implantation of endometriosis, laparoscopy, laparoscopic
procedure for endometriosis, endometriosis AND infertility, infertility, endometriosis
AND reproductive function, reproductive function, endometriosis AND uterine fibroids,
uterine fibroids, the general model of total patient delay, and the Andersen model.
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Theoretical Foundation
Various theoretical foundations have been used by researchers to study the delay
in diagnosis of endometriosis. Chilet-Rosell (2014) used the FST to study why
recognition of health problems specific to women (e.g., endometriosis and endometrial
cancer) have been slow over the years. According to the FST, women’s knowledge often
is excluded from the construction of ideology, and traditional science ignores and
marginalizes women’s way of thinking (Borland, 2016). Chilet-Rosell suggested that
there is gender bias in knowledge dissemination, often leading to the hindrance of the
discovery of diseases that impact women. Similarly, various theoretical foundations have
been used by researchers to study the link between endometriosis and infertility.
Galhardo, Moura-Ramos, Cunha, and Pinto-Gouveia (2015) used the social cognitive
theory and suggested that women who suffer from endometriosis and who are also
considered to be infertile present a perception of failure and defeat and also feel that there
is no solution to their infertility; women who do not suffer from endometriosis but also
are considered to be infertile do not feel the same perception of failure and defeat, nor the
feeling that there is no solution to their infertility.
Reducing diagnostic delays may result in improved prognosis for most disorders
(Walter et al., 2012). The general model of total patient delay, also known as the
Andersen model, can be used to explain delay in the stages of disease (e.g., appraisal,
illness, behavioral, scheduling, and treatment; Walter et al., 2012). The initial Andersen
model was used to predict and explain the use of health services, but was later revised to
include systematic concepts of health care (e.g., current policy, resources, and
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organization; Andersen & Newman, 1973). The second-generation model, however,
extended into outcomes of interest beyond use to consumer satisfaction (Andersen &
Newman, 1973). Eventually, the model began to include personal health practices as an
antecedent to outcomes, which involved the acknowledgement of health services and
satisfaction of health services among patients (Andersen & Newman, 1973). The latest
iteration of the Andersen model turns to individuals as the unit of analysis, going beyond
health care use and adopting health outcomes as the endpoint of interest (Andersen &
Newman, 1973). Different from similar theories, the Anderson model includes a feedback
loop to illustrate that health outcomes may affect aspects of health beliefs and need
(Andersen & Newman, 1973).
The Andersen model was used in this study as a means to support whether
diagnosis of endometriosis might pose a higher incidence for risk (i.e., infertility) based
on age. The model also aided in explaining of why certain time intervals exist between
onset of symptoms of endometriosis and formal diagnosis given that the model.
According to the Anderson model, diagnostic delay results from conceptual beliefs about
a person’s symptoms; behavioral factors, such as strategies for self-appraisal; and
techniques for coping with illness and emotional reaction (Walter et al., 2012). Evans,
Ziebland, and McPherson (2007) used the Andersen model to account for diagnostic
delays in a sample of British women with ovarian cancer. Evans et al. conducted
semistructured interviews with 43 women (ages 33-80 years; mean age: 54 years),
determining that most of the women (38 of 43 participants) reported prediagnostic
symptoms and diagnostic delays. The recording of patient delays conformed to
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Andersen’s first four types of delays: appraisal, illness, behavioral, and scheduling.
Furthermore, treatment delays, as drawn from Anderson’s model, included
noninvestigation of symptoms, treatment for noncancer causes, lack of follow-up, referral
days, and system delays (Evans et al., 2007). By using the Andersen model as an analytic
framework for the study, Evans et al. concluded why some British women experience
delays in obtaining ovarian cancer diagnosis. Furthermore, Evans et al. used the
analytical framework to explain how diagnostic delays for ovarian cancer could be
minimized.
In a correlational, quantitative study, Ozturk, Fleer, Hoekstra, Josetta, &
Hoekstra-Weebers (2015) used Andersen’s model of total patient delay to explain how
delay in diagnosis of testicular cancer (TC) could pose higher incidence for risk for
decreased survival. Ozturk et al. used a questionnaire to gain insight from 60 men (ages
17-45 years; median age: 26 years) who were diagnosed with TC at a university medical
hospital in the Netherlands. Using the Andersen model, Ozturk et al. concluded that the
median patient delay of 30 days (range 1-365 days) was due mostly to lower educated
men and men embarrassed about their scrotal change (r=-.25, r=.79, respectively.
Furthermore, Ozturk et al. used the model to support the conclusion that age, marital
status, TC awareness, warning signals, and perceived limitations were not associated with
patient delay. Ozturk et al. used the model to conclude that the most important risk
variable in general practitioners was misdiagnosis and that TC awareness programs could
decrease misdiagnoses and delays in diagnoses in order to improve disease survival.
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Literature Review Related to Key Variables and/or Concepts
Endometriosis
Endometriosis is the presence of endometrial-like tissue outside the uterus, and it
is a chronic disease associated with pelvic pain and subfertility (Nnoaham et al., 2011).
Endometriosis is most commonly known to affect the ovaries, fallopian tubes, and the
tissue lining the pelvis; although in rare cases, endometrial tissue has been found to
spread beyond the pelvic organs (Mayo Clinic, 2016). In the case that endometriosis
occurs, endometrial tissue that is displaced continues to act as it normally would by
thickening and breaking down and bleeding with each menstrual cycle (Mayo Clinic,
2016). However, because the displaced tissue is prohibited from exiting the body, it
becomes trapped and surrounds tissue, causing the tissue to become irritated, which
causes the development of scar tissue and adhesions, further leading to the fusion of
certain organs (Mayo Clinic, 2016).
Laparoscopy is a procedure used to diagnose endometriosis by inserting a lighted
viewing instrument (i.e., laparoscope) through a small incision; this is the most common
technique for removing mild to moderate endometriosis (WebMD, 2016). Laparoscopic
procedure works by viewing the internal organs to look for signs of endometriosis and by
removing visible endometriosis implants and scar tissue that causes pain or leads to
infertility (WebMD, 2016). Because a definitive diagnosis is established only at
laparoscopy, prevalence rates of endometriosis in the general population remains obscure
(Nnoaham et al., 2011). Based on community prevalence of symptoms, however, it is
estimated that endometriosis affects 10% of all women and 30%-50% of symptomatic
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premenopausal women (i.e., ~176 million women affected worldwide; Nnoaham et al.,
2011). Furthermore, the prevalence of endometriosis among fertile women is 0.5%-5%,
and the prevalence of endometriosis among infertile women is 25%-40% (Juneau
Biosciences, 2016).
Endometriosis Implantation/Location
Because endometriosis is an estrogen-dependent condition characterized by
endometrial glands and stroma outside the uterine cavity, implantations are found in the
peritoneum, the ovaries, and the rectovaginal septum, which constitute three different
disease entities (Burggmanet al., 2016). Via laparoscopic procedure, disease location and
phenotype (i.e., superficial, deep infiltrating, endometriomata) can be determined
(Menakaya, Lu, Infante, Lam, & Condous, 2014).
Menakaya et al. (2014) examined 104 women living with endometriosis.
Menakaya et al. found that the most common phenotype of endometriosis among the
women was superficial endometriosis, with sites of endometriosis located in the pelvic
area, on and below the ovaries, and deep in the pelvis area behind the uterus. The most
common diagnoses made among the sample of women via diagnostic laparoscopy for
pelvic pain consisted of pelvic endometriosis and adhesions (Menakaya et al., 2014). The
list of endometriosis implantations/locations among the women included the uterus,
ovaries, fallopian tubes, pouch of Douglas (POD), uterovesical fold, uterosacral
ligaments, rectovaginal space, left and right pelvic side walls (i.e., from pelvic brim to
ureteric tunnel), and peritoneal surfaces throughout the pelvis and upper abdomen
(Menakaya et al., 2014). Given all of the examined implantations/locations of
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endometriosis among the women, only 24/100 (23%) had a history of infertility, with
only 3/104 (2.9%) having undergone hysterectomy (Menakaya et al., 2014). There was
no correlation between the site of pain and location of the disease (Menakaya et al.,
2014).
Although the most common reason leading up to laparoscopic surgery–often
ending in diagnosis of endometriosis–is pelvic pain, variation in the sites of
endometriosis and how those sites may or may not affect chances of infertility are lacking
(Maggiore et al., 2016). Pereira and Kilgman (2016) found that a 31-year-old woman
presented to a clinic who had a 2-year history of infertility, when finally having
undergone laparoscopic surgery, was determined to have endometriosis on her right
fallopian tube. Whether the woman’s infertility was due to endometriosis or primary
infertility was, however, undetermined (Pereira & Kilgman, 2016). Consideration
regarding site/location in which endometriosis exists within a woman’s body might be
helpful in regards to assessing the potential association between age of women when
diagnosed with endometriosis and infertility, especially given that several variations in
fallopian tube anatomy are notable during the evaluation of infertility because disease
affecting the fallopian tubes account for nearly 25%-35% of all infertility cases (Pereira
& Kilgman, 2016).
Impact of Endometriosis on Women’s Lives
The prevalence of endometriosis among women with pelvic pain is 20%-90%,
although the etiology and pathogenesis is not known (Moradi et al., 2014). Often labeled
as the missed disease, the average time between the onset of pain and diagnosis is nearly
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8 years in the United Kingdom and nearly 12 years in the United States (Moradi et al.,
2014). The quality of life for many patients with endometriosis is negatively affected, and
some women experience the emotional impact of subfertility, anger about disease
recurrence, and uncertainty about the future in regard to repeated operations and/or longterm medical therapy (Moradi et al., 2014). Moradi et al. (2014) identified impaired
health related to quality of life and work productivity across countries and ethnicities,
further concluding that women continue to experience a delay in diagnosis. From a
sample of 35 women who were formally confirmed to have endometriosis via
laparoscopy diagnosis and who were purposely recruited in order to avoid potential bias,
Moradi et al. determined that most participants experienced pain, dyspareunia,
heavy/irregular bleeding, and infertility, and all suffered from severe and progressive
pain in areas such as the lower abdomen, bowel, bladder, lower back and legs during both
menstrual and nonmenstrual phases. Other symptoms reported to negatively impact the
women’s lives included fatigue, tiredness, bloating, bladder urgency, bowel symptoms
(e.g. diarrhea), bladder symptoms, and sleep disturbances due to intense pain (Moradi et
al., 2014).
Among the three age groups included in Moradi et al.’s (2014) study (e.g., 16-24
years; 25-34 years; >35 years), Moradi et al. also showed that the most detrimental
impact of endometriosis on the women’s lives stemmed from negative effects on
marital/sexual relationships, social life, and physical and psychological wellbeing. Most
of the participants were either married or had a partner and had a history of living with
endometriosis anywhere from 2 to 40 years (Moradi et al., 2014). The mean age in which
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endometriosis-related symptoms were first experienced were reported by the participants
to be 17.4 ± 6.8 years (range: 11-41), with diagnosis made at 25.6 ± 7.9 years (range: 1542), and delay in diagnosis of endometriosis found to be 8.1 ± 6 years (range: 3 months 24 years; Moradi et al., 2014). Furthermore, almost half of the participants (17 out of 35)
reported that endometriosis interfered with their life and only 54.3% of participants (19
out of 35) reported moderate satisfaction with their treatment (Moradi et al., 2014).
According to the American Society for Reproductive Medicine (ASRM), stages
of endometriosis are based on both the extent and location of endometriotic adhesions,
with minimal endometriosis (Stage I) being indicative of minimal or superficial ovarian
and peritoneal implants and severe endometriosis (Stage IV) consisting of deep, dense
endometriotic implants (North Shore Medical Center, 2016). There is no correlation
between stage and symptoms of endometriosis, which may result in misdiagnosis or
delayed diagnosis of endometriosis (Gao, Yeh, Outley, Simon, Botteman, & Spalding,
2008). Because two-thirds of women with chronic pelvic pain (CPP) in the United States
do not seek medical attention, Goa et al. (2008) evaluated the impact of endometriosis on
the lives of the particular population. Goa et al. used the conceptual model developed by
Wilson and Cleary, which states that biological and physiological variables may lead to
physical and psychophysical symptoms that affect a person’s functioning, general health
perception, and overall health related quality of life (HRQL).
Goa et al. (2008) examined studies that measured the HRQL impact of
endometriosis and its key symptoms; analyzed the impact of pharmacological and
surgical treatments of endometriosis on HRQL; and reviewed the literature pertaining to

26
the presence and impact of endometriosis in adolescents, who are considered to be an
overlooked patient population. Goa et al. found five dimensions of health status were
addressed, which consisted of mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression. Each of the five dimensions were divided into three levels: no
problem, some problem, or extreme problem (Goa et al., 2008). Goa et al. determined
that compared with a group of women not diagnosed with endometriosis, there were
unfavorable results among the endometriosis group in regards to inference with daily
activities, health distress, and pain during or after intercourse (p < 0.05 for all).
Furthermore, among those suffering from endometriosis, there were higher reports of
anxiety-depression, sleeplessness, irritability, dyspareunia, painful defecation, dysuria,
dysmenorrhea, and overall discomfort on the visual analogue scale (VAS; Goa et al.,
2008). According to Goa et al., although it is known that endometriosis impacts fertility
and sexuality, more researchers should focus on the impacts of endometriosis on the
ability to work, the ability to play, and the ability to invest in personal relationships.
Diagnostic delay is believed to worsen the effects of endometriosis on the
physical, emotional, and social wellbeing of patients and their ability to work (Giuliani et
al., 2015). Pelvic pain, which represents the clinical problem of the disease (manifesting
as dysmenorrhea, dyspareunia, chronic pelvic pain, and less frequently, dysuria and
dyschezia) results in adverse effects on women’s working abilities and psychosocial
functioning (Giuliani et al., 2015). General quality of life (QoL) and sexual satisfaction
are compromised in women with endometriosis (Giuliani et al., 2015). I stopped
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reviewing here due to time constraints. Please go through the rest of your chapter and
look for the patterns I pointed out to you. I will now look at Chapter 3.
An experimental study by Giuliani et al. (2015) aimed to evaluate QoL and sexual
satisfaction in a group of Italian women affected by endometriosis while identifying
specific sociodemographic variables that could impact the individual perception of the
disease. A survey was conducted on 150 women with endometriosis who were recruited
at a University hospital in Rome in the department of gynecology for service of
endometriosis and pelvic pain (Giuliani et al., 2015). The control group included 150
women who were considered to be healthy (e.g. not diagnosed with endometriosis) and
who were matched for age and relationship status. Age of participants ranged from 22-50
years (mean age=35.75; SD=6.90) (Giuliani et al., 2015). Sociodemographic
questionnaires (i.e. the Italian version of the World Health Organization Quality of Life Bref (WHOQOL-Bref), McCoy Female Sexuality Questionnaire (MFSQ), and the Visual
Analogue Scale (VAS)) also were administered to participants. WHOQOL-Bref was used
to assess the QoL perceived by participants in four different areas: physical,
psychological, social relationships and environmental; and MFSQ was used to assess
sexual and relationship satisfaction, analyzing two specific factors: sexuality and
partnership (Giuliani et al., 2015). The level of pain related to dysmenorrhea, chronic
pelvic pain, and dyspareunia were evaluated through VAS (e.g. 0=no pain, from 13=mild pain, from 4-7=moderate pain, from 8-10=severe pain) (Giuliani et al., 2015).
No statistical differences between the groups in relation to the sociodemographic
variables (e.g. educational level, marital status, employment status, etc.) were found
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except for the presence of children, with 86.7% of women in the experimental group not
having children compared to only 58.7% of women in the control group not having
children (Giuliani et al., 2015). Interestingly, though, data did show that the experimental
group obtained a lower score than did the control group in the questionnaire total scores
in terms of the sexual satisfaction domain (P<0.01) (MFSQ) and the physical,
psychological and social relationships domains (P=0.00) (WHOQOL-Bref) (Giuliani et
al., 2015).
Results from the experimental study suggest that clinical symptoms presented by
endometriosis such as pain, tissue fibrosis, chronic inflammatory status, and the presence
of neuroactive agents can severely affect sexual life (Giuliani et al., 2015). For example,
women with endometriosis were found to be much less satisfied with their QoL in
general, as well as in physical health, psychological and social relations domains when
compared with women without endometriosis (Giuliani et al., 2015). Furthermore,
women with endometriosis were found to have less sexual satisfaction than women
without endometriosis (Giuliani et al., 2015). Given the higher percentage of women
without children in the experimental group (86.7%) versus the percentage of women
without children in the control group (58.7%), it is possible that many women without
children in the experimental group faced problems of infertility – which actually was not
explored in the aforementioned study. Given that there is a reason to believe that healthrelated quality of life is greater among parents than non-parents in regards to emotional
support (Eiser & Varni, 2013), perhaps the quality of life of women with endometriosis in
the study would have been greater if problems related to infertility were non-existent.
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With that being said, assessing an impactful association between time in diagnosis of the
disease and infertility in women might yield answers that provide a better quality of life
for women who suffer from the disease by allowing them to conceive. In order determine
such impactful association, though, formal diagnosis must first take place before
appropriate options for treatment can be made available (Endometriosis Association,
2016).
Treatment
From patients’ point-of-view, endometriosis is a nightmare of misfortune, myths,
lack of diagnosis, and problematic “hit-and-miss” treatments, all of which are overlaid by
the painful, chronic, stubborn disease (Moradi et al., 2014). Although there is no cure for
endometriosis, there are a variety of treatment options that aim to relieve/reduce pain
symptoms, shrink or slow down endometrial growths, preserve or restore fertility, and
prevent and/or delay recurrence of the disease (Endometriosis Association, 2016). Such
treatment options include: pain medication in the form of over-the-counter pain relievers,
for instance aspirin and acetaminophen, as well as prostaglandin inhibitors like ibuprofen,
naproxen sodium, indomethacin, tolfenamic acid, and in some cases the requirement of
prescription drugs; pain relief such as ProSirona, which is a new product that targets
endometriosis and is applied topically on the area of pain with the main ingredients being
essential oils combined in a technologically advanced way; hormonal therapy aimed to
stop ovulation for as long as possible, such as oral contraceptives, progesterone drugs,
testosterone derivatives (e.g. danazol), and GnRH agonists (gonadotropin releasing
hormone drug); surgery, which seeks to remove and destroy endometrial growths, relieve
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pain, and increase the chances of pregnancy; and last, alternative treatments such as
traditional Chinese medicine, nutritional approaches, homeopathy, allergy treatment, and
immune therapy (Endometriosis Association, 2016).
When it comes to perceptions of endometriosis-related treatment, overall, the
ideal outcome of surgical intervention in patients suffering from endometriosis-related
infertility is for the anatomical relationship to be restored and for the function of the
pelvic organs to be preserved (Gizzo et al., 2014). An observational cohort study by
Gizzo et al. (2014) compared two large cohorts (Group A and Group B) of infertile
women affected by endometriosis who underwent laparoscopic treatment strictly for the
purpose of restoring/improving their fertility by either a skilled surgeon (Group A) or a
surgeon strictly dedicated to endometriosis-related infertility (Group B). Comparisons
among the two groups were made in regards to perioperative surgical outcomes,
clinical/ongoing pregnancy and live birth rates, spontaneous pregnancy rate, and
obstetrical outcome (Gizzo et al., 2014). Participants included in the study consisted of
women aged 18-42 years, who had a preoperative suspicion of endometriosis confirmed
by histology, who had a history of infertility, and who had a desire of pregnancy (Gizzo
et al., 2014). Furthermore, participants were required to be of Caucasian ethnicity, have
no history of previous concomitant malignant disease, no severely impaired ovarian
reserve, and no systemic diseases which potentially could interfere with fertility (e.g.
diabetes and disthyroidism) (Gizzo et al., 2014).
After it was determined that there was a significantly higher spontaneous fertility
rate (particularly in the first year after surgery) and lower ectopic pregnancy rate in
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Group B post surgery, Gizzo et al. (2014) concluded that in patients affected by
endometriosis, the choice should be personalized in regards to deciding between
expectant management versus intervention. For example, in the case that estimated
probability of natural conception is low, surgery may need to be considered as a secondline treatment. However, in all other cases, surgery should be offered early (i.e. as a firstline approach) as it can improve the chance of spontaneous conception (Gizzo et al.,
2014).
Due to difficulty in long-term management of endometriosis symptoms and
unpredictability of treatment outcomes, treatment options such as herbal medicine stand
necessary in endometriosis research (Stephens, Whitehouse, & Polley, 2013). With that
being said, a study by Stephens, Whitehouse, & Polley (2013) reviewed commonly used
herbs in the treatment of endometriosis, the effects of phytochemical constituents on
endometrial cells, and the impact such treatment had on the epigenome. Stephens et al.
(2013) defined treatment of endometriosis as reduction of pain and prevention of pain
recurrence. Long history of documented evidence regarding herbal medicine for
endometriosis-like symptoms has led to an increase in popularity of herbal medicine,
specifically in the West, for treating endometriosis in attempt to overcome poor longterm success at resolving chronic pain or recurrence of the disease using conventional
intervention (Stephens et al., 2013). Recent data on dienogest (a 19-nortestosterone
derivative) for pain management in endometriosis presented by the Royal College of
Obstetricians and Gynecologists (RCOG) actually reports, for example, that women with
endometriosis prefer complementary medicine (e.g. herbal medicine) over nonsteroidal
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anti-inflammatory drugs (NSAIDs) and analgesics (Stephens et al., 2013). Such increase
in preference regarding herbal treatment was found to be attributed to known effects on
the signaling pathways associated with pathogenesis of endometriosis, further
demonstrating anti-proliferative, antioxidant, analgesic, and inflammatory effects on
endometrial cells (Stephens et al., 2013).
Unfortunately, standard medication and surgical treatments of endometriosis
show high recurrence of symptoms (Prather, MacLean II, Shi, Boadu, Paquet, & Hayashi,
2016). Due to such high rates of recurrence, it is suggested that current treatment options
be improved (Prather et al., 2016). Long-term treatment of patients who experience
chronic pelvic pain associated with endometriosis often involves repeated courses of
therapy, whether surgical, medical or both (Prather et al., 2016). Laparoscopic surgery,
for example, is found to provide relief of symptoms from the disease, only to have an
estimated 50% recurrence rate after five years (Prather et al., 2016). Furthermore, GnRH
agonist therapy is estimated to have a 50% or even higher rate of recurrence of symptoms
over time (Prather et al., 2016). With that being said, it is suggested that therapeutic
targets and efficient drugs that potentially could be improvements over current treatment
options be identified (Prather et al., 2016).
In an experimental study by Prather et al. (2016), it was examined whether the
non-steroidal drug niclosamide could be a useful drug for endometriosis in a preclinical
setting. Niclosamide is defined as an efficacious, minimally toxic and FDA-approved
anti-helminth drug that has been used in patients for decades (Prather et al., 2016).
Niclosamide is reported to aid in the disruption of multiple signaling pathways including
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NFĸB, STAT3, and WNT signaling in a variety of cancer models (Kim et al., 2013).
Given the history of the drug in cancer models, it was hypothesized that the drug could be
an inhibitor of endometriosis progression by blocking signaling pathways (Prather et al.,
2016). For the experimental study, endometriotic implants were surgically inserted into
donor mice who were currently experiencing the diestrus stage of the reproductive cycle
(Prather et al., 2016). After 3 days of recovery, recipient mice received niclosamide
orally at a dose of 0 (n=8), 100 (n=5), or 200 (n=10) mg/kg b.w./per day for 3 weeks.
More than 95% of mice ate their completed dosage of niclosamide within 30 minutes
(which was mixed in gelatin with artificial flavors for taste). After the 3 weeks of
treatment, the recipient mice were necropsied, and the endometriotic implants were
distinguished under a Fluorescence Stereo Microscope and collected for further analysis
(Prather et al., 2016). Further analysis included determining whether there was an effect
of niclosamide treatment on reproductive functions, where mice then were randomly
assigned for control (n=11) or niclosamide (n=7) group.
A significant difference in the pattern of growth of the endometriotic implants
were discovered, with niclosamide treated mice at a dose of 100 mg/kg b.w./per day
having showed a significant reduction of implant weight (0.023 ± 0.004 g) and growth
(4.63 ± 1.00 fold from initial implant size) compared to controls (implant weight: 0.044 ±
0.007 g, and growth: 8.66 ± 1.10 fold) (Prather et al., 2016). Furthermore, niclosamide
treated mice at a dose of 200 mg/kg b.w./day also presented a reduced implant weight
(0.016 ± 0.003 g) and growth (1.90 ± 0.40 fold) compared to controls (Prather et al.,
2016). Importantly, it was found that niclosamide had no effect on reproductive function,
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as all mice exposed to niclosamide became pregnant and gave birth (Prather et al., 2016).
Also, there were no alterations in regard to gestational length, number of pups, and
weight of pups at birth upon the mice being exposed to niclosamide (Prather et al., 2016).
Such results from the experimental study indicate that treatment (i.e. niclosamide)
can be effective for endometriosis, acting as an inhibitor of inflammatory signaling
without disrupting normal reproductive functioning (Prather et al., 2016). As an
important contribution to the present study, though, Prather et al. (2016) presented the
importance regarding the stage in which the female mice were treated. For example,
specifically given the fact that the recipient mice were strictly selected to receive
treatment in the case that they were undergoing the diestrus stage, which is equivalent to
the estrus stage in humans, classifying women as being at the most effective reproductive
stage in their life (Kim et al., 2016), a 100% success rate in regards to reproduction from
the mice post treatment provides support as to how effective treatment for endometriosis
can be in regards to fertility if presented at an appropriate time.
Association Between Endometriosis and Infertility
Infertility typically is defined as the inability of couples to become pregnant after
12 months of regular unprotected sexual intercourse (Thoma et al., 2013). Endometriosis
is considered to be the number one cause of infertility in the United States, having a
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women (Juneau
Biosciences, 2016). With that being said, in vitro fertilization (IVF) is represented as the
most successful means of achieving conception in endometriosis patients struggling with
infertility (Surrey, 2015). Interestingly, Surrey (2015) explored the impact of
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endometriosis on IVF cycle outcomes as well as whether surgical or medical
management of endometriosis could impact success rates. Conclusions formulated by the
review study suggested that women with endometriosis have similar cycle outcomes to
other patients going through IVF who do not suffer from endometriosis although several
earlier studies such as Barnhart et al. (2002) and Barcelos et al. (2009) suggested poorer
outcomes associated with IVF from women suffering from endometriosis in comparison
to controls (Surrey, 2015). The conclusion of the study, which suggested that women
with endometriosis have similar success rates to other patients going through IVF could
be flawed, however, given the fact that the study did not control for other infertility
variables that could have affected the outcome (Surrey, 2015). Importantly, discrepancy
between Surrey (2015) and earlier studies was assumed to be attributed to the decreasing
role of laparoscopy as a means to diagnose endometriosis in order to further explore
potential infertility issues. For example, some patients in the study who potentially could
have been suffering from endometriosis but who had never undergone laparoscopy were
classified with the diagnosis of “unexplained infertility” (Surrey, 2015).
Although diagnosed in asymptomatic patients, endometriosis usually is diagnosed
when patients present with pain and/or claims of infertility (Burghaus et al., 2016). With
that being said, endometriosis actually is diagnosed during laparoscopy in a quarter of
patients with infertility (Burghaus et al., 2016). Although various etiologies have been
discussed and proposed, such as potential causes of infertility due to endometriosis being
linked to anatomical changes of the adnexa, the association between endometriosis and
infertility still remains unclear (Burghaus et al., 2016). Other etiologies, though, include
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changes to the immunological milieu for implantation affecting sperm motility, as well as
uterotubal transport disorders, and disorders of oocyte maturation (Burghaus et al., 2016).
Although published pregnancy rates for patients with endometriosis range from 24%54%, such estimated rates are thought to be an overestimation given that some patients
may not have attempted spontaneous pregnancy prior to surgery for endometriosis
(Burghaus et al., 2016).
Endometriosis is considered to be one of the most challenging clinical entities for
gynecologists given the extreme difficulty linked to managing pain and infertility
(McKenzie, 2015). With that being said, a study by McKenzie (2015) assessed a case
study regarding the effects of endometriosis on infertility and suggests that “less is more”
in regard to surgical management for endometriosis-associated infertility. The study
assessed a case concerning a 34-year-old patient who presented a complaint to her
physician in 2014 regarding infertility after attempting pregnancy for two years.
However, the patient was only recently diagnosed with endometriosis via laparoscopy in
December 2013 (McKenzie, 2015). Interestingly, before the diagnosis of endometriosis,
prior fertility testing via ultrasound on the patient determined an occluded left Fallopian
tube and an anti-Mullerian hormone (AMH) level of 1.6 ng per mL (McKenzie, 2015).
Furthermore, via transvaginal ultrasound, bilateral endometriomas measuring
approximately 5 and 10 cm were suspected (McKenzie, 2015). Fertility management (i.e.
IVF) was immediately discussed versus the option of removing the endometriomas. Six
months after the discovery of the suspected endometriomas, the patient decided to
undergo IVF, which turned out to be unsuccessful (McKenzie, 2015). McKenzie (2015)
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further concluded that although incidence of endometriosis can be asymptomatic in
women trying to become pregnant/claiming to be suffering from infertility, laparoscopic
diagnosis of endometriosis is important in regards to battling infertility. Given that
laparoscopy for evaluation of endometriosis-associated infertility varies dramatically
between 9%-50%, exactly how endometriosis impacts fertility remains uncertain
(McKenzie, 2015). With that being said, perhaps assessing the association between the
age in which a woman is diagnosed with endometriosis and infertility could help explain
what currently is considered to be “unexplained infertility”.
Presence of Uterine Fibroids
Uterine fibroids are common, benign, smooth-muscle tumors that are known to
cause major morbidity for women of reproductive age, often requiring them to undergo
invasive treatment (Baird et al., 2015). Although uterine fibroids are considered, by
many, to be both a personal and public health burden, there is a lack of studies that
attempt to periodically screen women with ultrasound in order to detect incident disease
and/or identify risk factors (Baird et al., 2015). Interestingly, uterine fibroids develop in
the majority of reproductive-age women and are considered to be the leading cause of
hysterectomy in the United States (Baird et al., 2015).
Heavily impacting women’s health and fertility, endometriosis and uterine
fibroids are common indications for surgery (Ciarmela, Critchley, Christman, & Reis,
2013). A better understanding of the conditions – especially together – are essential for
the development of successful medical therapies and are of interest to many clinicians
and clinical researchers (Ciarmela et al., 2013). Although uterine fibroids and
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endometriosis are known to contribute to a considerable amount of pain, potentially
leading to subfertility or infertility in women, the relationship between the two is poorly
understood (Nezhat et al., 2016). Nezhat et al. (2016) conducted a retrospective study in
order to assess the rate of coexistence of endometriosis in women with symptomatic
leiomyoma (i.e. uterine fibroids). The retrospective review collected medical records of
244 patients treated at a tertiary medical center, who were evaluated for symptoms of
uterine fibroids. Out of the 244 patients, 208 of those underwent laparoscopic procedure,
where 181 had concomitant diagnoses of uterine fibroids and endometriosis (Nezhat et
al., 2016).
The most common form of uterine fibroids amongst the participants existed as
solid pelvic tumors, which, alone, is known to affect 20%-25% of reproductive-aged
women (Nezhat et al., 2016). Alarmingly, out of the 20%-25% of women who suffer
from uterine fibroids in the form of solid pelvic tumors, 50% are usually symptomatic,
where the symptoms are considered to depend on the number, size, and location of the
tumor (Nezhat et al., 2016). The most common symptoms associated with uterine fibroids
include abnormal uterine bleeding, pelvic pain, and extreme pressure, and risk factors
include increased estrogen stimulation, family history of uterine fibroids, and race
(Nezhat et al., 2016). Uterine fibroids seldom are the sole cause of infertility, but become
a major concern when coexisting with endometriosis (Nezhat et al., 2016). Interestingly,
Nezhat et al. (2016) suggested that dismissal of the diagnosis of endometriosis during
surgical intervention for uterine fibroids can result in suboptimal treatment – especially in
patients with chronic pelvic pain, infertility, or both. All in all, Nezhat et al. (2016) found
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that because of the significant overlap of symptoms between uterine fibroids and
endometriosis, it often is difficult to discern which pathology is responsible for patients’
complaints. Nezhat et al. (2016) further concluded that because patients who have
symptomatic uterine fibroids may be at a higher risk for endometriosis and vice versa,
suspicion for both endometriosis and uterine fibroids should be of equal concern when
patients undergo laparoscopic procedure.
Despite uncertainty regarding the relationship between uterine fibroids and
endometriosis, through advances in pathogenetic knowledge of uterine fibroids, it has
been suggested via studies such as Tocci et al. (2008) that sites in which pathological
thickening or abnormality of sub-endometrial tissue occur also serve as the possible sites
of origin of submucosal and intramural fibroids (Ciavattini et al., 2013). Furthermore,
Ciavanttini et al. (2013) mentioned that although in current time, it is not well established
exactly how uterine fibroids might interfere with the endometrial environment and the
sub-endometrial environment and vice versa, patients who suffer from both
endometriosis and uterine fibroids definitely have an increased risk for infertility and/or
miscarriage, strictly due to influences related to the association between the two
conditions.
Summary and Conclusions
Endometriosis is considered to be the number one cause of infertility in the
United States, with diagnoses of the disease found to be delayed anywhere from 7-10
years, and the disease being poorly recognized by physicians in practice (Juneau
Biosciences, 2016; Johnston et al., 2015). This study is significant to the research topic
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because it might increase the understanding of the issue concerning the lack of
knowledge that exists in regards to the association between endometriosis and infertility;
specifically in regards to how the age in which a woman is diagnosed with the disease
might affect her ability to conceive.
The literature presented data on the prevalence of endometriosis, as well as the
average years of delay that exists in regards to definitive diagnosis. The review further
demonstrated the impact of endometriosis on women, such as pain, dyspareunia,
heavy/irregular bleeding, and infertility, which significantly affects their daily lives
(Moradi et al., 2014). The literature revealed patients’ point-of-view regarding treatment
for the disease and how available treatment options are problematic in that they often are
found to be “hit-and-miss,” even though most patients undergo treatment with the
perception that the anatomical relationship regarding fertility can be restored and the
function of the pelvic organs will be preserved (Moradi et al., 2014; Gizzo et al., 2014).
A number of studies have established a connection between endometriosis and
infertility, but no researchers have considered the association between the age in which a
woman is diagnosed with endometriosis and infertility. This study attempted to fill the
gap in the literature by determining if there is a statistically significant association
between the age in which a woman is diagnosed with endometriosis and being considered
infertile. Chapter 3 will provide an overview of the research design and methodology.
The discussion will include the target population; sampling and sampling procedures,
including justification for effect size, alpha level, and power level; data collection
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procedures, including access to secondary data; threats to validity; and ethical
procedures.
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Chapter 3: Research Method
Introduction
Diagnosis of endometriosis is delayed and poorly recognized by physicians in
practice, often leading to misdiagnosis and/or suboptimal care (Johnston et al., 2015). In
addition, investigation concerning causes of female infertility is receiving less attention.
An optimal approach to managing infertility requires a method associated with routine
and timely measures (Bell, 2014). However, scholars have not explored the association
between the age of a woman when diagnosed with endometriosis and infertility. Earlier
diagnosis of the disease (e.g., diagnosis at an earlier age) could serve as a preventative
strategy towards infertility. If a statistically significant association between age of women
when diagnosed with endometriosis and infertility is determined, there could be fewer
incidences of endometriosis-related infertility. Furthermore, determining a statistically
significant association also could provide for more effective patient/doctor visits for
women who suffer from common symptoms of endometriosis.
In Chapter 3, I will explore the research design and rationale of the study, explain
the system of methods used in order to carry out the study, introduce any factors that
could serve as threats to the validity of the study, explain ethical procedures involved in
the gathering of data, and include a brief introduction to Chapter 4.
Research Design and Rationale
Quantitative researchers focus on gathering numerical data to generalize results
across groups of people or to explain a particular phenomenon (USC Libraries, 2016).
Furthermore, quantitative methods are used to emphasize measurements and statistical,
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mathematical, or numerical analyses of data through the collecting of polls,
questionnaires, and surveys, or by manipulating preexisting statistical data using
computational techniques (USC Libraries, 2016). The goal of a quantitative study is to
determine the relationship between one thing (i.e., the independent variable) and another
(i.e., the dependent variable) within a population (USC Libraries, 2016). In this
quantitative study, I aimed to determine whether there was an association between the
age in which a woman was diagnosed with endometriosis and infertility. The dependent
variable in the study was infertility, and the independent variable in the study was age.
Because I also aimed to determine how history of uterine fibroids and site/location of
endometrioma influenced the association between age of women when diagnosed with
endometriosis and infertility, uterine fibroids and site/location were used as covariates in
the study.
The research design for this study was a cross-sectional design. The crosssectional study design is considered to be one of the most common and well-known study
designs (Olsen & St. George, 2004). In cross-sectional studies, either an entire population
or a subset of a population is selected, and data from individuals within the population or
subset population are collected to answer research questions (Olsen & St. George, 2004).
A cross-sectional research design was appropriate for this study because data on a group
of women diagnosed with endometriosis in Eastern North Carolina were assessed in order
to answer the research questions.
Epidemiologists analyze preexisting data to find answers to questions (Olsen &
St. George, 2004). A secondary data analysis of preexisting data retrieved from medical
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records of patients at multiple OB-GYN clinics in Eastern North Carolina was used for
this study. Incorporating secondary data from patients’ medical records allowed me to
search through a wider range of materials covering larger areas over longer periods of
time in shorter duration than would have been possible using only primary data. By using
statistical analysis, I could better understand the historical context behind patients’
medical struggle with endometriosis. For example, via preexisting medical records, I was
able to assess–through physician documentation–when patients first complained of onset
of symptoms related to endometriosis, when patients underwent laparoscopic surgery to
definitively diagnosis endometriosis, whether or not they were considered to be suffering
from infertility, and the age in which all series of events took place.
These research designs are needed to advance knowledge in the social sciences
discipline because they provide a basis for describing patterns of relation or association
between variables (Frankfort-Nachmias & Nachmias, 2008). By using a cross-sectional
research design, I was able to investigate the association between variables to further
contribute to the knowledge concerning the association between endometriosis and
infertility.
Methodology
Population
The target population for this study was women living in Eastern North Carolina,
between the ages of 18 and 35 years, who were formally diagnosed with endometriosis
via laparoscopic surgery. The pool of eligible women whose medical records were
assessed for this study was made available by physicians. In the medical records, the
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women stated that they underwent laparoscopic surgery (at some point in time, with the
date of surgery noted) and were diagnosed with endometriosis following the procedure.
Further, medical records from the pool of eligible women provided information regarding
whether or not there currently was an issue with infertility.
The women who were eligible for this study were identified by number (ie.,
Patient 1, Patient 2, Patient 3, and so forth. Information concerning the date in which the
patient underwent laparoscopic surgery, their current age, whether or not they had a
history of uterine fibroids, where their sites of endometriosis occurred, and whether or
not they experienced/had experienced issues with infertility were listed separately
according to the patient.
Because that the target population was women between the ages of 18-35 years
who had been diagnosed with endometriosis via laparoscopic procedure in Eastern North
Carolina, the sample from the target population was retrieved by assessing the medical
records of women who lived/visited a clinic in several of Eastern North Carolina’s largest
counties: Pitt County, Wayne County, Lenoir County, Bladen County, Jones County, and
New Hanover County.
The target population was not restricted by race, as all racial/ethnic groups were
considered. The sample size for this study consisted of 102 women who had been
diagnosed with endometriosis. The sample size was calculated using G*Power version
3.0.10 under the parameters 80% statistical power, an alpha of .05, and an effect size of
.5. A statistical power of .80 was chosen so that I could find a real treatment effect (or
mean difference) 80% of the time. For example, if the study were repeated 100 times, the
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null hypothesis would be rejected 80 times–if there is indeed an effect (Burkholder, n.d.).
An alpha level of .05 was used so that there would only be a 5% chance for making a
Type I error, incorrectly rejecting the null hypothesis (Burkholder, n.d.). Last, the effect
size of .5 simply was preferred to achieve a medium effect size.
Sampling and Sampling Procedure
Preexisting medical records from a sample of approximately 102 women of
multiple races/ethnicities, residing in Eastern North Carolina, suffering from
endometriosis was used for this study. The factor of race/ethnicity was not be considered
for this study because similar rates of endometriosis are observed among women of
different races (Gerlinger et al., 2012). Only women between the ages of 18 and 35 years
were used for this study as such age group is considered to be within good standards in
regard to reproduction, with women’s fertility decreasing substantially by their late 30s
(Lezzoni et al., 2014). Women who are over the age of 35 were excluded to avoid the
factor of age as a possibility for infertility. Preexisting medical records that were assessed
were retrieved from OB-GYN clinics located in Eastern North Carolina.
Inclusion and exclusion criteria determined eligibility for the assessment of
medical records of patients. Inclusion criteria were the following: women who were
formally diagnosed with endometriosis (i.e., Stage I or Stage II) residing in Eastern North
Carolina between the ages of 18-35, and women who provided full consent for their
medical records to be assessed for research purposes. Diagnosis of endometriosis was
assessed according to documentation in the medical records of each patient stating that
the patient underwent laparoscopic surgery on a day within a certain year. Any other
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diagnoses presented in the medical records–aside from diagnosis of uterine fibroids–were
not be assessed. Exclusion criteria included the following: women who suspected
endometriosis but had avoided formal diagnosis via laparoscopic procedure, women not
between the ages of 18-35, women who did not provide full consent for their medical
records to be assessed, and women diagnosed with Stage III (or moderate) or Stage IV (or
severe). If there was no indication of laparoscopic surgery presented in a patient’s
medical record (i.e., no documented date of laparoscopic surgery), such patient was
excluded from the study, and if a patient was found to possess multiple locations of deep
adhesions or implants (i.e., implants/adhesions involving multiple organs), those patients
were excluded as well.
As previously stated, the study consisted of preexisting medical records from a
sample of 109 women. The sample size was calculated using G*Power version 3.0.10
under the parameters 80% statistical power, an alpha of .05, and an effect size of .5.
Given those parameters, it was suggested that the study contain a sample size of 102. I
was, however, able to achieve a slightly higher sample size. My reasoning for choosing a
statistical power of .80 was so I could insure a real treatment effect 80% of the time,
rejecting the null hypothesis 80 times in the case that the study was repeated 100 times, if
there was indeed an effect (Burkholder, n.d.). For there to only be a 5% chance for
making a Type I error, or incorrectly rejecting the null hypothesis, an alpha level of .05
was used. Last, the effect size of .5 simply was preferred to achieve a medium effect size.
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Archival Data
The data collection process for this study required institutional review board
(IRB) approval to assess secondary data in the form of patient medical records from OBGYN clinics in Eastern North Carolina. IRB approval documents, along with the data use
agreement form, were presented to physicians prior to the assessment of patient medical
records. Physicians whom agreed to serve as my data provider signed the data use
agreement form and asked me to sign a HIPAA confidentiality agreement form in the
case that not all medical records were de-identified. Once the HIPAA confidentiality
agreement forms were signed by physicians as well as myself, I was allowed temporary
access to medical records of patients who suffered from and had been diagnosed with
endometriosis. In the case that any patients were not diagnosed with endometriosis, their
medical records remain nondisclosed to me.
Data Analysis Plan
The software that was used for the analysis of this study included IBM SPSS
Statistics Version 24. SPSS was used to perform statistical regression analysis to assess
the association between age of women when diagnosed with endometriosis (i.e., the
independent variable) and infertility (i.e., the dependent variable). Furthermore, statistical
regression analysis and stratified analysis was used to test for confounding by assessing
the association between age of women when diagnosed with endometriosis and infertility
when a second independent variable (e.g., history of uterine fibroids) was introduced. The
research questions and hypotheses for this study included
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RQ1: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for history of uterine fibroids?
H01: There is no statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
H11: There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
RQ2: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for the specific sites of endometriosis?
H02: There is no statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
H12: There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
The analysis included conducting multiple logistic regression to determine
potential associations between variables. For example, age of women when diagnosed
with endometriosis (i.e., age) served as the independent variable on a continuous scale,
with ages ranging between 18 and 35 years. More specifically, ages of women were not
be dichotomized into groups. Fertility status (i.e., infertility) served as the dependent
variable on a binary scale where women were coded in the dataset as being fertile or
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infertile (i.e., fertile=0; infertile=1). The variable history of uterine fibroids (i.e., uterine
fibroids) was introduced as a potential confounding variable in the association between
the variables age and infertility To test whether history of uterine fibroids might act as a
confounding variable–affecting the association between age of women when diagnosed
with endometriosis and infertility–a stratified analysis was performed to examine the
primary association at different levels of the potential confounding variable. For example,
the association between age of women when diagnosed with endometriosis and infertility
was tested separately among women with a history of uterine fibroids and among women
without a history of uterine fibroids. In the initial analysis, before the effect of history of
uterine fibroids was taken into consideration, uterine fibroids was be coded in the dataset
as 0=nonpresence of uterine fibroids and 1=presence of uterine fibroids. Patients who
suffer from endometriosis often suffer from uterine fibroids as well, and both are
considered to potentially lead to subfertility or infertility in women (Uimari et al., 2011).
For the second research question, age of women when diagnosed with endometriosis (i.e.,
age) served as the independent variable on a continuous scale, and fertility status (i.e.,
infertility) served as the dependent variable. Instead of including the variable uterine
fibroids into the analysis, implantation/site location of endometriosis (i.e., site) was
included, with the variable coded (1=ovaries, 2=fallopian tubes, 3=uterus, 4=bladder, 5=
rectum, etc.).
The results were interpreted via scatterplots, which presented whether or not there
was a statistically significant association between the age in which women are diagnosed
with endometriosis and infertility. I also determined the usefulness of the logistic
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regression model in terms of measuring the association between variables.
Crosstabulation, or a contingency table analysis, was performed. Table 1 represents the
aforementioned data analysis plan:
Table 1
Data Analysis Plan
Research Questions

Variables

Statistical Analyses

RQ1: What is the

IV: Age when diagnosed

Test: Logistic Regression;

association between age of

with endometriosis.

ANOVA; Crosstabulation

women when diagnosed

DV: Infertility

with endometriosis and

Covariate: History of

infertility after controlling

Uterine Fibroids

for history of uterine
fibroids?
RQ2: What is the

IV: Age when diagnosed

Test: Logistic Regression;

association between age of

with endometriosis.

Crosstabulation

women when diagnosed

DV: Infertility

with endometriosis and

Covariate: Site/Location of

infertility after controlling

endometriosis

for specific sites of
endometriosis?
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Access to Secondary Data
Access to secondary data in the form of electronic patient medical records was
obtained by contacting multiple clinics in Eastern North Carolina by both phone and email. After physicians at certain clinics agreed to allow me access to patient medical
records, I personally met with each of the physicians at the clinics and presented them
with a data use agreement form that was signed by myself, as well as the physicians who
were responsible for granting me access to the medical records necessary for answering
my research questions. All of the medical records used for the study were either deidentified so that patients’ names, addresses, and other forms of contact information were
not be available to me, or a HIPAA confidentiality form was signed to protect the
identities of those whose charts were not de-identified.
Threats to Validity
External Validity
External validity explains the extent to which conclusions can be generalized to a
wider population and/or across populations, treatments, settings/contexts, and time
(Laureate Education, 2012). External validity is important in quantitative research due to
because researchers strive to be able to report that their conclusions gathered from their
research can be generalized, although the results are based solely on a sample (Laureate
Education, 2012). With quantitative research designs, the level of external validity is
affected by potential threats that may influence the ability to make generalizations
(Laureate Education, 2012). The four main threats to external validity in quantitative
research include selection biases; constructs, methods, and confounding; real world
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versus experimental world; and history effects and maturation (Laureate Education,
2012). I stopped reviewing here. Please go through the rest of your chapter and look for
the patterns I pointed out to you. I will now look at Chapter 4.
Given that this study included a secondary data analysis of existing
medical records, selection bias could have been an issue given the fact that only medical
records of women portraying specific factors, such as in age, race/ethnicity, marital
status, and socioeconomic status were assessed (Laureate Education, 2012). Such threat
to external validity, however, was addressed by assessing medical records of women of
all races/ethnicities, marital statuses, socioeconomic statuses, and races/ethnicities.
Assessing the medical records of women belonging to a wide variety of ages, ranging
from the teens to mid-thirties, also addressed such threat to external validity.
Furthermore, since extraneous variables also can limit the generalizability of results by
studying only certain characteristics within a sample/population (i.e. endometriosis), such
threat the validity was addressed by taking history of uterine fibroids into consideration
when studying the association between the independent and dependent variables as well
(Laureate Education, 2012). By addressing such threats, the sample is more generalizable
to larger populations of women suffering from endometriosis, possibly facing infertility.
Internal Validity
Internal validity explains the extent to which our conclusions made from our
dissertation research accurately reflect what we are studying (Laureate Education, 2012).
With that being said, as researchers, we want to be able to state our conclusions with as
much certainty as possible. In quantitative studies, internal validity can be affected by the
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type of quantitative research design adopted (i.e. descriptive, experimental, etc.) and
potential threats (Laureate Education, 2012). Threats to internal validity might include:
instrumentation, selection bias, history effects, testing effects, statistical regression, and
compensation (Laureate Education, 2012). Again, given that this study uses a secondary
analysis of existing medical records, and no actual patients were needed for the study,
internal validity was high.
Construct Validity
Construct validity refers to the extent to which a measurement procedure
measures given constructs in a study (Laureate Education, 2012). In other words,
construct validity is viewed as the process that researchers go through in order to assess
the validity of a measurement procedure (e.g. questionnaire) when used to measure a
given construct (e.g. depression, trust, commitment, etc.) (Laureate Education, 2012). For
construct validity to exist, a clear link between the construct of interest and the measures
and/or interventions used to operationalize it should be clear; and furthermore, a clear
distinction between constructs should exist (Laureate Education, 2012). With that being
said, there are a number of threats to construct validity, which include: inexact definitions
of constructs, mono-operation bias, reducing levels of measurements of constructs,
mono-method bias, treatment-sensitive factorial structure, and construct confounding
(Laureate Education, 2012).
In order to avoid such threats, broad constructs of interest were narrowed down
and adequate definitions of constructs were provided. Furthermore, given that this study
consisted of one independent variable (i.e. age) and one dependent variable (i.e.
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infertility), taking into consideration the co-variates and potential confounding variables
“uterine fibroids” and “sites/locations,” threats to construct validity in regards to
construct confounding were addressed by thoroughly explaining how the constructs
uterine fibroids and endometriosis relate to one another, as well as explaining the
boundaries between the two, and how differences in site/location of endometriosis
provide for different outcomes (Laureate Education, 2012).
Ethical Procedures
In order to ensure that the study was conducted ethically, the protection of
patients whose medical records were assessed was taken highly into consideration. This
study was conducted in compliance with ethical standards provided by Walden
University. Informed consent and the assessment of medical records received Walden
IRB approval prior to the initiation of the study. For example, IRB was contacted via email, and all study procedures (e.g. requirement of obtaining de-identified patient medical
records) were presented to IRB prior to data collection. As suggested by IRB, a Data Use
Agreement form was signed by myself as well as physicians as an agreement to gain
temporary access to patient medical records for use in research in accord with laws and
regulations of the governing bodies associated with the Data Provider (i.e. physicians),
Data Participant (i.e. myself), and Data Participant’s educational program (i.e. Walden
University). The signed Data Use Agreement document was submitted along with my
IRB application, which was formally approved before any data was assessed. Patient
medical records remained inside the clinics at all times during the assessment process.
Furthermore, I was not allowed to leave the clinics with any medical records at any time
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as to ensure confidentiality and avoid dissemination. As the student researcher, I was the
only individual allowed access to the medical records aside from the physicians of the
clinics. Importantly, the names, addresses, and telephone numbers of patients whose
medical records were assessed were not disclosed in the study. The IRB approval number
for this study is: 07-11-17-0561657.
Summary
In this chapter, I discussed the research design, methodology, data collection and
analysis plan, threats to validity and ethical considerations associated with the study. A
detailed explanation of how this study was conducted in order to obtain and gather the
data necessary to determine whether or not an association exists between the age in which
a woman is diagnosed with endometriosis and infertility was provided. The purpose of
this study, which was to fill the gap concerning whether an association exists between the
time in which a woman is diagnosed with endometriosis (i.e. age of woman when
diagnosed) and infertility was thoroughly explained. In Chapter 4, I will present the
results of the analysis of the data collected in the study.
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Chapter 4: Results
Introduction
The purpose of this study was to determine whether an association between the
age of women when diagnosed with endometriosis and infertility existed. Both uterine
fibroids and endometriosis are known to lead to subfertility or infertility in women; yet,
the relationship between the two is poorly understood. In this study, I also aimed to
determine whether an association between the age of women when diagnosed with
endometriosis and infertility existed when history of uterine fibroids also was present.
Further, given that site/location of endometrioma might affect the association between
infertility and the age in which a woman is diagnosed with endometriosis, I also aimed to
determine the affect different sites/locations have when assessing the relationship
between infertility and the age in which a woman is diagnosed with endometriosis.
The research questions this study aimed to answer included the following:
RQ1: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for history of uterine fibroids?
H01: There is no statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
H11: There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for history of uterine
fibroids.
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RQ2: What is the association between infertility and age of women when
diagnosed with endometriosis after controlling for the specific sites of endometriosis?
H02: There is no statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
H12: There is a statistically significant association between infertility and age of
women when diagnosed with endometriosis after controlling for the specific sites of
endometriosis.
In Chapter 4, I will present the findings of this study, as well as the data collection
process. The sample size for this study was calculated using G*Power version 3.0.10
under the parameters 80% statistical power, an alpha of .05, and an effect size of .5. A
statistical power of .80 was chosen so that I could expect to find a real treatment effect
(or mean difference) 80% of the time. An alpha level of .05 was used so that there would
only be a 5% chance for making a Type I error, incorrectly rejecting the null hypothesis
(Burkholder, n.d.). Last, the effect size of .5 simply was preferred to achieve a medium
effect size. An accurate sample size for the study consisted of 102 women diagnosed with
endometriosis. After collecting necessary data, however, I was fortunate to receive data
on a total of 109 who satisfied my inclusion criteria.
Data Collection
The data for this study were collected over a period of 3 weeks, with the time
frame ranging from December 4, 2017 to December 22, 2017. Although I was able to
retrieve the data in a short period of time, the process for meeting all requirements by the
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clinics/hospitals before the actual retrieval of data was permitted was lengthy. For
example, to retrieve data from the clinics/hospitals, I was required to receive several
vaccinations and present proof of updated vaccination records, and I also was required to
present both a state and federal level background check to each of the clinics/hospitals.
Although I received my state background check within a few weeks, retrieval of my
federal background check took a total of 4 months to receive, having applied for one in
July 2017 and not receiving feedback from the FBI until the end of October 2017.
Without both the state and federal background checks presented to the hospitals/clinics,
physicians were unable to sign my data use agreement forms, which were required to
complete my IRB application.
Once IRB permitted me to proceed with the collection of my data, all physicians
were immediately contacted, and all physicians worked around their schedules to
accommodate my needs. After I visited with all clinics/hospitals approved in my IRB
application, a total of 109 participants were assessed for this study. All of the participants
were women between the ages of 18 and 35 who were diagnosed with endometriosis via
laparoscopic procedure. Any medical charts gathered for my assessment that included
women outside of the inclusion criteria were excluded from the study. For example,
several participants, I found, were not within the age criteria, and some participants
presented to physicians with suspicion of endometriosis, but never underwent
laparoscopic procedure to confirm a diagnosis. The final analysis of this study was
conducted on 109 patients, with a power analysis conducted to calculate achieved power,
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using an appropriate alpha level (α = .05), sample size (n = 109), and effect size (η2 = .5).
The achieved power was calculated to be 0.80.
All data retrieved for this study consisted of preexisting medical records from a
sample of 109 women of multiple races/ethnicities, residing in Eastern North Carolina,
who suffered from endometriosis. The factor of race/ethnicity was not considered in this
study because similar rates of endometriosis are observed among women of different
races (Gerlinger et al., 2012). Only women between the ages of 18 and 35 years were
used for this because such an age group is considered to be within good standards in
regard to reproduction, with women’s fertility decreasing substantially by their late 30s
(Lezzoni et al., 2014). Women over the age of 35 were excluded from the study to avoid
the factor of age serving as a possibility for infertility. I did not include data on women
who possessed multiple locations of deep adhesions or implants (i.e., implants/adhesions
involving multiple organs), as I wanted to compare how site/location of endometrioma
might affect the association between infertility and the age in which a woman was
diagnosed with endometriosis, separately. All medical records assessed were retrieved
from OB/GYN clinics/hospitals located in Eastern North Carolina.
Because this study included a secondary data analysis of existing medical records,
selection bias could have been an issue if only medical records of women portraying
factors (ie., in age, race/ethnicity, marital status, and socioeconomic status) were assessed
(Laureate Education, 2012). Such threat to external validity, however, was addressed by
assessing medical records of women of all races/ethnicities, marital statuses,
socioeconomic statuses, and races/ethnicities. Assessing the medical records of women
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belonging to a wide variety of ages, ranging from the teens to mid-30s, also addressed
such threats to external validity. Furthermore, because extraneous variables also can limit
the generalizability of results by studying only certain characteristics within a
sample/population (i.e., endometriosis), such threats the validity were addressed by
taking history of uterine fibroids into consideration when studying the association
between the independent and dependent variables (Laureate Education, 2012). By
addressing such threats, the sample was more generalizable to larger populations of
women suffering from endometriosis, possibly facing infertility.
Results
Descriptive Statistics
Participant characteristics. As part of the inclusion criteria, all participants were
required to be between the ages of 18 and 35 years and had had been diagnosed with
endometriosis, with diagnoses having been documented in the medical records of each
patient. All patients with the presence of uterine fibroids–along with their diagnosis of
endometriosis–were gathered from documentation in the medical records. Descriptive
statistics for the continuous variable age are presented in Table 2.
Table 2
Descriptive Statistics

Age

N

Minimum

Maximum Mean

Median

109

18

35

29

28.59

Std.
Deviation
5.403

Frequencies and percentages for age. Out of 109 participants aged 18 to 35
years, the most common age at time of diagnosis was 35 years, with 17 women (15.6%)
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being aged 35 when diagnosed with endometriosis. The second most common age at time
of diagnosis was 33 years, with 14 women (12.8%) being aged 33 when diagnosed with
endometriosis. In turn, the least common age at time of diagnosis was 23 years, with only
one patient (0.9%) being 23 when diagnosed with endometriosis. The frequency for age
is presented in Table 3.
Table 3
Frequency for Age
Age

Frequency

Percent (%)

18
19
20
21
22
23
25
26
27
28
29
30
31
32
33
34
35

4
7
3
2
7
1
4
6
7
8
7
6
5
3
14
8
17

3.7
6.4
2.8
1.8
6.4
0.9
3.7
5.5
6.4
7.3
6.4
5.5
4.6
2.8
12.8
7.3
15.6

Frequencies and percentages for fertility status. Out of 109 participants, only
30 participants (27.5%) were considered to be suffering from infertility, while 79
participants (72.5%) expressed no concerns of infertility, despite endometriosis diagnosis.
The frequency for fertility status is presented in Table 4.
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Table 4
Frequency for Fertility Status
Fertility Status

Frequency

Percent (%)

Fertile
Infertile
Total

79
30
109

72.5
27.5
100.0

Frequencies and percentages of site/implantation. Out of 109 participants, the
most frequent location for endometriosis occurred equally amongst the ovaries and the
fallopian tubes, with 34 participants (31.2%) found to have endometrioma on their
ovaries and 34 participants (31.2%) found to have endometrioma on their fallopian tubes.
The least frequent location amongst the study sample was the rectum, with only two
(1.8%) participants found to have endometrioma located on their rectum. By assessing
the frequencies for the site/locations of endometrioma amongst the study sample, I
determined that two of the five site/locations (i.e., bladder and rectum) had low cell
counts when a crosstabulation is performed. The frequencies for site/location of
endometrioma is presented in Table 5.
Table 5
Frequencies for Site/Location of Endometrioma
Site/Location

Frequency

Percent (%)

Ovaries
Fallopian
Tubes
Uterus
Bladder
Rectum

34
34

31.2
31.2

28
11
2

25.7
10.1
1.8
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Total

109

100.0

Frequencies and percentages of uterine fibroids. Out of 109 participants diagnosed
with endometriosis, only 14 women (12.8%) had reported uterine fibroids. The majority
of endometriosis patients in the sample, consisting of the remaining 95 women (87.2%),
had not reported uterine fibroids. The frequency for uterine fibroids is presented in Table
6.
Table 6
Frequency for Uterine Fibroids
Uterine
Fibroids
No
Yes
Total

Frequency

Percent (%)

95
14
109

87.2
12.8
100.0

Analysis of variance of the data. One-way ANOVA was performed for age and
fertility status. The number of fertile woman in the sample was 79, with the mean age
being 27.51 years, which presented a lower bound of 26.22 years and an upper bound of
28.79 years. The number of infertile women in the sample was 30, with the mean age
being 31.43 years, which presented a lower bound of 30.32 years and an upper bound of
32.55 years. Further, the minimum age for those women considered fertile was 18 years,
while the maximum age was 35 years. The minimum age for those women considered
infertile, however, was 26 years; although, the maximum age also was 35 years.
According to the ANOVA statistics, on average, the fertile women were of younger age
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when diagnosed with endometriosis than the infertile women. The p-value was found to
be statistically significant with p=.001. The means are presented in Table 7.
Table 7
ANOVA Descriptives
A
g
e

95% C.I
for Mean

Fertile
Infertile
Total

N

Mean

St.
deviation

St.
Error

79
30
109

27.51
31.53
28.59

5.735
2.979
5.408

.645
.544
.518

Lower
Bound
26.22
30.32
27.56

Upper
bound

Minimum

Maximum

28.79
32.55
29.61

18
26
18

35
35
35

Note. (P=.001)
A contingency table analysis for uterine fibroids and fertility status was
performed. Regarding the entire study population (n=109), it was determined that the
majority of the fertile population (78.9%) did not have a presence of uterine fibroids, and
only 28.6% of the fertile population did have a presence of uterine fibroids. Further, it
was determined that the majority of the infertile population (71.4%) did have a presence
of uterine fibroids, with only 21.1% of the infertile population not having a presence of
uterine fibroids. From the crosstab results, amongst the study sample, women diagnosed
with endometriosis who also have fibroids were more likely to be infertile. The p-value
was calculated to be .000, which was statistically significant. Therefore, there was a
statistically significant association between uterine fibroids and fertility status. The
crosstabulation for uterine fibroids and fertility status is presented in Table 8.
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Table 8
Fibroids and Fertility Status Crosstabulation
Fibroids

Frequencies

No
95
Yes
14
Total
109
Note. (P=.000)

Fertile

Infertile

Total

78.9%
28.6%
72.5%

21.1%
71.4%
27.5%

100.0%
100.0%
100.0%

Last, a contingency table analysis for site/location of implantation of
endometrioma and fertility status was performed. Regarding the participants who were
considered to be facing issues with infertility (n=30), the majority (44.1%) experienced
endometrioma on their ovaries, followed by 41.2% of the infertile having experienced
endometrioma on their fallopian tubes, and only 3.6% of the infertile having experienced
endometrioma on their uterus. None (of the infertile participants [0.0%]) were found to
be suffering from endometrioma on their bladder or rectum. From the crosstab, there was
a small cell count for location of endometrioma on the bladder and on the rectum (e.g.,
expected count <5). The p-value for the Fisher’s Exact Test was calculated to be .000,
which was statistically significant. Therefore, there was a statistically significant
association between site/location of implantation of endometrioma and fertility status.
The crosstabulation for uterine fibroids and fertility status is presented in Table 9.
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Table 9
Implantation and Fertility Status Crosstabulation Fisher’s Exact
Site/Implantation Frequencies Fertile
Location
Ovaries
Fallopian Tubes
Uterus
Bladder
Rectum
Total
Note. (P=.000)

34
34
28
11
2
109

55.9%
58.8%
96.4%
100.0%
100.0%
72.5%

Infertile

Total

44.1%
41.2%
3.6%
0.0%
0.0%
27.5%

100.0%
100.0%
100.0%
100.0%
100.0%
100.0%

Research Question 1
What is the association between age of women when diagnosed with
endometriosis and infertility after controlling for history of uterine fibroids?
Hypothesis 1
Null hypothesis: There is no statistically significant association between age of
women when diagnosed with endometriosis and infertility after controlling for history of
uterine fibroids.
Alternative hypothesis: There is a statistically significant association between age
of women when diagnosed with endometriosis and infertility after controlling for history
of uterine fibroids.
Infertility and age when diagnosed with endometriosis. A logistic regression was
performed to determine the effects of the independent variable (i.e. age when diagnosed
with endometriosis) on the likelihood that participants suffer with infertility without
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considering the effects of the covariates (i.e. history of uterine fibroids, site/location of
endometrioma).
The model summary determined a -2 Log likelihood of 115.182 a, with a Cox and
Snell R square of .113 and a Nagelkerke R square of .164. These statistics provide
incentive that 11.3%-16.4% of the variability in the dependent variable (i.e. infertility) is
accounted for by the independent variable (i.e. age when diagnosed with endometriosis).
The model summary table is presented in Table 10.
Table 10
Model Summary
Step
1

-2 Log
Cox &
likelihood Snell R
Square
a
115.182
.113

Nagelkerke
R Square
.164

A Hosmer and Lemeshow test was performed, which presented a chi-square of
9.658 and a p-value of .209. Given that the p-value is greater than .05, we learn that the
model is significant in regard to the data. The Hosmer and Lemeshow test is presented in
Table 11. Furthermore, given concern for which participants are considered to be infertile
and whether or not the predictor variables are predicting infertility, the differences
between observed and expected fertile versus infertile participants were calculated.
Observing the differences between the observed and expected fertile versus infertile
patients, again, provides evidence that there is no indication of poor fit in regard to the
model; with the model, for example, predicting ~9 (8.782) out of 11 participants’ fertility
status. The contingency table for the Hosmer and Lemeshow test is presented in Table 12
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Table 11
Hosmer and Lemeshow Test
Step

Chisquare

Df

Sig.

1

9.658

7

.209

Table 12
Contingency Table for Hosmer and Lemeshow Test

1
2
3
4
5
6
7
8
9

Fertile
Observed
Expected

Infertile
Observed

11
12
9
12
6
4
10
4
11

0
0
2
3
7
4
4
4
6

10.392
10.979
9.291
11.863
9.514
5.310
8.400
4.470
8.782

Expected
.608
1.021
1.709
3.137
3.486
2.690
5.600
3.530
8.218

Total
11
12
11
15
13
8
14
8
17

.
The overall predictive capacity of the model when only looking at the association
between the independent variable (i.e. age) and the dependent variable (i.e. infertility)
was determined to be 72.5%, which indicates that although the model is not strong, it is
significant. The classification table is presented in Table 13.
Table 13
Classification Table
Observed
Fertility

Fertile

Fertile

Infertile

79

0

Percentage
Correct
100.0

70
Infertile

30

0

.0
72.5

Overall
Percentage

Again, the B value for age was found to be .170, which can be interpreted to mean
that greater values of age at time of diagnosis (e.g. increases in age) are associated with
greater probability of being infertile. In other words, a 1-unit (e.g. 1-year) increase in age
is associated with a .170 increase in the logit variable – or the probability of being
infertile. Given that the p-value for age is .001, the variable is still considered to be a
statistically significant predictor of infertility. Last, with an odds ratio of 1.185, it can
further be concluded that a 1-unit (e.g. 1-year) increase in age is associated with a 1.185
times greater odds of experiencing infertility. Importantly, the analysis was interpreted
with the variable “age” being measured on a continuous scale – with ages ranging from
18-35 years. In other words, the variable “age” was not categorized in to specific age
groups. With that being said, it is appropriate to report that compared to a woman
diagnosed with endometriosis at age 18 years, a woman diagnosed with endometriosis at
age 35 years has a higher odds of experiencing infertility. Variables in the equation are
presented in Table 14.

Table 14
Variables in the Equation

Age

B

S.E.

Wald

Df

Sig.

95%
for
Exp(B) Lower

.170

.053

10.153

1

.001

1.185

1.067

C.I.
Exp(B)
Upper
1.315

71
Constant -6.001

1.649

13.249

1

.000

.002

Presence of uterine fibroids. A logistic regression was performed, taking the
covariate “uterine fibroids” into consideration in order to determine the effects of the
independent variable (i.e. age when diagnosed with endometriosis) on the likelihood that
participants suffer with infertility. With the variable “uterine fibroids” present, the odds
ratio for age experienced a slight decrease, but remained statistically significant (pvalue=.011), and the odds ratio for fibroids was 6.300, which also was found to be
statistically significant (p-value=.006). With an Exp(B) of 6.300, we learn that patients
with uterine fibroids have a 6.3 times greater odds of having infertility after controlling
for age. In other words, presence of uterine fibroids was found to be a stronger
independent predictor than age. Importantly, the results showed that the odds of infertility
are higher for the women in the study sample who were diagnosed at an older age even
after adjusting for fibroids. Variables in the equation are presented in Table 15.
Table 15
Variables in the Equation

B
Age
.141
Fibroids 1.841
Constant -5.426

S.E.

Wald

Df

Sig.

95%
for
Exp(B) Lower

.055
.666
1.684

6.530
7.641
10.384

1
1
1

.011
.006
.001

1.151
6.300
.004

1.033
1.708

C.I.
Exp(B)
Upper
1.282
23.232

A Hosmer and Lemeshow test was performed after the variable “uterine fibroids”
was introduced, which presented a chi-square of 14.317 and a p-value of .074. Given that
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the p-value is greater than .05, again, we learn that the model adequately describes the
data. The Hosmer and Lemeshow test is presented in Table 16. Given concern for which
participants are considered to be infertile and whether or not the predictor variables are
predicting infertility when presence of uterine fibroids is introduced, the differences
between observed and expected fertile versus infertile participants were calculated.
Again, the contingency table for the Hosmer and Lemeshow test provides evidence that
there is no indication of poor fit in regard to the model; with the model, for example,
predicting 4 out of 4 participants’ fertility status as being fertile and predicting 10 out of
10 participants’ fertility status as being infertile. The contingency table for the Hosmer
and Lemeshow test is presented in Table 17.
Table 16
Hosmer and Lemeshow Test
Step

Chisquare

Df

Sig.

1

14.317

8

.074

Table 17
Contingency Table for Hosmer and Lemeshow Test

1
2
3
4
5
6

Fertile
Observed
Expected

Infertile
Observed

11
12
8
12
6
4

0
0
1
3
6
3

10.371
11.020
7.785
12.379
9.381
5.124

Expected
.629
.980
1.215
2.621
2.619
1.876

Total
11
12
9
15
12
7

73
7
8
9
10

9
3
10
4

6.868
4.591
7.481
4.000

1
4
2
10

3.132
2.409
4.519
10.000

10
7
12
14

Research Question 2
What is the association between age of women when diagnosed with
endometriosis and infertility after controlling for specific sites of endometriosis?
Hypothesis 1
Null hypothesis: There is no statistically significant association between age of
women when diagnosed with endometriosis and infertility after controlling for specific
sites of endometriosis.
Alternative hypothesis: There is a statistically significant association between age
of women when diagnosed with endometriosis and infertility after controlling for specific
sites of endometriosis.
Site/location of endometrioma. A logistic regression was performed, taking the
covariate “site/implantation” into consideration in order to determine the effects of the
independent variable (i.e. age when diagnosed with endometriosis) on the likelihood that
participants suffer with infertility. Specifically, dummy variables were made for each
site/location (i.e. implantation(1)=ovaries; implantation(2)=fallopian tubes;
implantation(3)=uterus; and implantation(4)=bladder) except for the dummy variable
“rectum”, which was used as a reference category. Output from the logistic regression,
however, showed that the model was poorly fit. The logistic regression for fertility status
and site/location of implantation is presented in Table 18. Further, the chi-square test
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also provided indication of poor fit, with three cells (30%) having an expected count of
less than 5. The chi-square test is provided in Table 19. Therefore, testing research
question 2 was not possible. However, referencing back to Table 9, the contingency table
analysis for implantation and fertility, the only information we can gather in regards to
RQ2 is that out of the participants who were considered to be facing issues with infertility
(n=30), the majority (44.1%) experienced endometrioma on their uterus, which was
proceeded by 41.2% of the infertile participants having experienced endometrioma on
their fallopian tubes, and then only 3.6% of the infertile participants having experienced
endometrioma on their uterus. Interestingly, none of the infertile participants (0.0%) were
found to be suffering from endometrioma specifically on their bladder or rectum.
Importantly, the p-value was calculated to be .000, which is statistically significant. From
that, the only conclusion that can be made from those results – in regard to the second
research question – are that there is a statistically significant association between
site/location of implantation of endometrioma and fertility status amongst the study
sample.
Table 18
Logistic Regression for Variables in the Equation

Age
Implantation
Implantation(1)
Implantation(2)
Implantation(3)
Implantation(4)

B

S.E.

Wald

Df

Sig.

Exp(B)

95%
for
Lower

.206

.072

.004
.041
.999
.999
.999
1.000

1.068

26465.582
26465.582
26465.582
28703.660

1
4
1
1
1
1

1.228

21.214
20.860
16.819
.272

8.247
9.969
.000
.000
.000
.000

1633916054
1146835331
20150132.92
1.313

.000
.000
.000
.000

C.I.
Exp(B)
Upper
1.414
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Fibroids
Constant

2.630 1.120
5.516
26465.582 .000
27.650

1
1

.019
.999

13.847
.000

13.847 124.567
.000

Table 19
Chi-Square Statistics
Value

Df

Asymptotic
Significance
(2-sided)

Pearson Chi20.860
4
.000
Square
Likelihood Ratio
26.909
4
.000
Linear-by-Linear 16.710
2
.000
Association
N of Valid Cases 109
27.5%
100.0%
a. 3 cells (30.0%) have expected count less than 5. The minimum expected count is .55.

Summary
The purpose of the study was to determine whether an association exists between
the time in which a woman is diagnosed with endometriosis (i.e. age of woman when
diagnosed) and infertility after controlling for covariates of site/location of implantation
of endometrioma (i.e. implantation) and presence of uterine fibroids (i.e. fibroids). In
regard to RQ1, it was determined that a statistically significant association exists between
age of women when diagnosed with endometriosis and infertility after controlling for
history of uterine fibroids; thus, the null hypothesis for research question one was
rejected. However, in regard to RQ2, due to low cell counts for the nominal variable
“site/location” of endometrioma, the desired logistic regression analysis was not valid;
hence, making it impossible to answer research question two. Only from the contingency
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table analysis (Table 8) regarding RQ2 could it be concluded that there is a statistically
significant association between site/location of implantation of endometrioma and
fertility status amongst the study sample, with higher percentages of endometrioma found
on the ovaries and fallopian tubes amongst those women considered to be infertile; lower
percentages of endometrioma found on the uterus amongst those women considered to be
infertile; and no reports of endometrioma located on the bladder or rectum amongst those
women considered to be infertile (p=.000).
The findings of this study will be discussed further in Chapter 5, comparing the
results and the statistical findings to existing literature. Chapter 5 also will provide a
detailed discussion concerning the limitations of the study, implementing incentive for
future research on the current study topic.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this quantitative, cross-sectional study was to determine whether
association existed between the age of women when diagnosed with endometriosis and
infertility after controlling for the covariates site/location of implantation of
endometrioma and presence of uterine fibroids among women in Eastern North Carolina.
Diagnosis of endometriosis has been found to be delayed anywhere from 7-10 years and
is considered to be poorly recognized by physicians in practice, often leading to
misdiagnosis and/or suboptimal care (Johnston et al., 2015). Earlier diagnoses of the
disease (e.g., diagnosis at an earlier age) could serve as a preventative strategy towards
infertility.
Before this study, the age of women when diagnosed with endometriosis and the
effects age at time of diagnosis might have on likelihood of infertility had not been
studied (American Society for Reproductive Medicine, 2012). The findings of the study
are expected to provide more information about the disease. Further, the study may
supply readers with knowledge regarding the topic, which is expected to better help
individuals recognize and understand normal menstrual cycles versus abnormal menstrual
cycles, as well as normal symptoms associated with menstrual cycles versus serious
abnormal pain that can be linked to endometriosis.
I took a quantitative approach, which was appropriate for measuring an
association between variables (Creswell, 2013). The cross-sectional design consisted of a
secondary data analysis of existing medical records of patients formally diagnosed with
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endometriosis. Logistic regression analysis was performed with age acting as the
independent variable, fertility acting as the dependent variable, and fibroids and location
of endometrioma acting as covariates. A contingency table analysis also was performed
to determine which age group(s) and which site(s)/location(s) were most commonly
associated with infertility.
In the findings of the study, I found a statistically significant association between
infertility and age in which a woman is diagnosed with endometriosis exists. Further,
there was no indication of evidence of poor fit regarding the model used to determine the
association between variables. The covariates, uterine fibroids, and site/location of
implantation of endometrioma were both found to influence the association between
infertility and the age in which a woman is diagnosed with endometriosis.
Interpretation of the Findings
The overall scope of the study was to determine the association between infertility
and the age in which a woman is diagnosed with endometriosis. The population of this
study consisted of 109 women aged 18 to 35 years. The most common age at time of
diagnosis within the study population was found to be the oldest age in the study sample
(i.e., 35 years), with 17 women (15.6%) being aged 35 years when diagnosed with
endometriosis. The second most common age at time of diagnosis within the study
population was 33 years, with 14 women (12.8%) being aged 33 years when diagnosed
with endometriosis, which also is one of the oldest ages at time of diagnosis within the
study population. The least common age at time of diagnosis was 23 years, with only one
patient (0.9%) being aged 23 years when diagnosed with endometriosis. In contrast to the
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most common age at time of diagnosis (i.e., 35 years), which also was the oldest age
considered in the study population, age 23 years at time of diagnosis was one of the
youngest ages at time of diagnosis within the study population. Further, the youngest age
at time of diagnosis in the study population (i.e., 18 years), accounted for only four of the
109 participants in the study population (3.7%). These frequency statistics for ages at
time of diagnosis for the study population can be considered consistent with claims that
endometriosis diagnoses are delayed (i.e., diagnosed at a later age opposed to a younger
age). Many patients claim to have a long history of doctor visits due to lower abdominal
and pelvic pain, receiving no support from physicians in regard to the pain aside from
being written a prescription for painkillers (Johnston et al., 2015). The frequency
statistics for ages at time of diagnosis for the study population reflected such claims given
that older ages (i.e., 33-35 years) at time of diagnosis were more common than younger
ages (i.e., 18-23 years) at time of diagnosis.
Uterine fibroids and endometriosis may be associated with each other (Nezhat et
al., 2016; Uimari et al., 2011). Although uterine fibroids seldom are the sole cause of
infertility in women, they become a concern when coexisting with endometriosis,
especially because of significant overlap of symptoms between endometriosis and uterine
fibroids when it is difficult to discern which pathology is responsible for patients’
complaints (Nezhat et al., 2016). Further, patients who suffer from both endometriosis
and uterine fibroids have an increased risk for infertility, which is thought to be due to
influences related to the association between the two conditions (Ciavattini et al., 2013).
The first research question addressed in this study included the following: What is the
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association between infertility and age of women when diagnosed with endometriosis
after controlling for history of uterine fibroids?
Although I found that most of the population considered to be suffering with
infertility did not have a history of uterine fibroids (66.7%), in a logistic regression
analysis, I determined that patients within the study population had a 6.3 times greater
odds of having infertility based on age when diagnosed with endometriosis when a
history of uterine fibroids was present, than when based off age of diagnosis alone.
Further, the value associated with the effects of uterine fibroids on the association
between age at time of diagnosis and infertility was found to be statistically significant
(p-value=.006).
The most common phenotypes of endometriosis among women is superficial
endometriosis, with sites of endometrioma located in the pelvic area, most commonly
presented on and below the ovaries (Menakaya et al., 2014). Variation in the sites of
endometrioma and how those s sites may or may not affect chances of infertility are
lacking (Maggiore et al., 2016). The second research question addressed in this study
included the following: What is the association between infertility and age of women
when diagnosed with endometriosis after controlling for the specific sites of
endometriosis?
The frequency analysis for site/location of implantation of endometrioma was
found to be consistent with the literature in that the majority of the 109 participants
(31.2%) in the study population had an area of concern located on the ovaries. However,
the exact same percentage of participants (31.2%) in the study population had an area of
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concern located on the fallopian tubes. Disease affecting the fallopian tubes accounts for
nearly 25%-35% of all infertility cases (Pereira & Kilgman, 2016). In the contingency
table analysis for site/location of implantation of endometrioma and infertility, I found
that out of the 30 participants who were considered to be infertile, the majority, or 15 out
of 30 (50%), had endometrioma located on the ovaries, where 14 out of 30 (46.7%)
participants who were considered to be infertile had endometrioma located on the
fallopian tubes. I stopped reviewing here. Please go through the rest of your chapter and
look for the patterns I pointed out to you. I will now look at your references.
Beyond the scope of the literature, however, the association between infertility
and the age in which a woman is diagnosed with endometriosis when considering the
covariate “site/location” of implantation of endometrioma could not be determined from
this study given the inability to answer research question two due to low cell count for the
nominal variable “site/location”. However, from the contingency table analysis, it could
be concluded that there is a statistically significant association between site/location of
implantation and fertility status (p=.000).
Limitations of the Study
This study contained several limitations. The first limitation includes the fact that
this study uses a secondary analysis of existing data. One major limitation regarding the
conducting of a secondary analysis of existing data includes the fact that the data was not
originally collected to address the particular research question or to test the particular
research hypotheses (Cheng & Phillips, 2014). Another major limitation regarding the
conducting of a secondary analysis of existing data for this study includes the fact that I,
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as the researcher, was not involved in the initial data collection process; therefore, being
unaware of any nuances in the data collection process that might be important to the
interpretation of the key variables (Cheng & Phillips, 2014). A third limitation relates to
the fact that race/ethnicity among women whose medical charts were assessed was not
taken into consideration. Perhaps the association between the age in which a woman is
diagnosed with endometriosis and infertility, even after taking the covariates site/location
of implantation of endometrioma and presence of uterine fibroids into consideration,
might differ when the factor of race is considered, even though endometriosis rates are
considered to be very similar among races (Gerlinger et al., 2012). A fourth limitation
relates to the fact that marital status of women whose medical charts were assessed also
was not taken into consideration. Perhaps such sociodemographic variable could
influence fertility status among the study population given that married couples are more
likely to try to conceive than unmarried couples (Laplante, & Fostik, 2015). For example,
given that some of the younger participants in the study population (i.e. 18-21 years)
might not be married and/or trying to conceive, the status from their medical charts
stating that they are considered to not be infertile (or not struggling with infertility issues)
might not be accurate given that they might not be at a stage in their lives where they are
trying to have a baby or are even sexually active. The most important limitation to
consider for this study is the fact that there simply were not enough cases in the study
sample. Had there been more cases, it is likely that there would have been a higher cell
count for the specific site/locations of endometrioma that currently are lacking. Due to
low cell count for the variable site/location of implantation of endometrioma, research
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question two simply could not be answered. As previously mentioned, perhaps more
controls such as race and marital status – to name a few – could have contributed to the
relevance of this study.
Recommendations
I have a few recommendations for further study. The first recommendation for
further study involves repeating this study with a broader cross-section among study
participants. For example, a larger sample size might strengthen the generalization of the
study results in regard to how accurately they reflect and represent a broader population.
The second recommendation for further study involves introducing more covariates to be
considered when assessing the association between infertility and the age in which a
woman is diagnosed with endometriosis. Introduction of more covariates could, for
example, further control for any potential confounding effects on the association between
variables. In other words, I would recommend taking race/ethnicity into consideration, as
race/ethnicity might have effects on infertility, alone. Further, taking marital/relationship
status into consideration might affect whether an individual is sexually active or not;
hence, trying to conceive versus not trying to conceive. Such covariate could better
represent the fertility status of participants, especially given that single participants might
not be evaluated to be suffering from infertility, but given their marital/relationship
status, may actually be unaware of infertility due to not being sexually active and/or not
trying to conceive. For example, there were study participants in my sample population
who were diagnosed with endometriosis but not documented to be suffering from
infertility. With that said, it is possible that the data used for this study is flawed given
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that fertility status for some of the participants diagnosed with endometriosis and not
considered to be suffering from infertility might solely be due to the fact that some of
those participants are single and/or not sexually active. All in all, future research should
include a significantly higher count of both cases and variables.
Implications
Social Change
The findings of the study might lead to social change by adding new evidence to a
topic within women’s health that has been considered a controversial topic for far too
long (Kovacs, 2015). The findings of the study are expected to provide accurate
information for the use of disproving currently existing information and theories about
the disease that perhaps are false/misleading. The study is expected to serve as an asset
for supplying readers with knowledge regarding the topic, which ultimately is expected to
better help individuals recognize and understand “normal” menstrual cycles versus
abnormal menstrual cycles, as well as “normal” symptoms associated with menstrual
cycles versus serious abnormal pain that can be linked to endometriosis. The study also
is expected to serve as evidence for why physicians should be more concerned for
endometriosis being diagnosed carefully and more promptly. Furthermore, in regard to
social change, the study hopefully will be able to provide a sense of support for women
who suffer from the disease, inspiring them not to overlook health emergencies out of
fear or frustration that physicians might dismiss them. Women should be made aware
that effective treatment is available if they seek it. The study also is expected to promote
social change by further supporting the devastating effects of endometriosis that burden
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women and their families since the disease currently is not recognized as a medical
disability (Jones, 2016). In regard to the study results, specifically, social change is
expected to be implemented by preventing infertility amongst woman who suffer from
both endometriosis and uterine fibroids, who are at risk for infertility due to the cluster of
endometriosis and uterine fibroids, together. In other words, preventative programs aimed
at better educating women on the risks of endometriosis and uterine fibroids should be
better implemented.
Theoretical Framework
Again, the theoretical framework for this study consisted of the General Model of
Total Patient Delay, also known as “the Andersen Model,” which is widely used for a
variety of disorders (Walter, Webster, Scott, & Emery, 2012). The theory suggests that
reducing diagnostic delays may result in improved prognosis for most disorders (Walter
et al., 2012). With that said, the Andersen Model explains important aspects regarding
delay stages (e.g. appraisal, illness, behavioral, scheduling, treatment) and was used in
the current study as a foundation for whether diagnosis of endometriosis poses a higher
incidence for risk (i.e. infertility) based on age – especially upon considering the covariates uterine fibroids and site/location of implantation of endometrioma. The
theoretical model also aided in the explanation of why certain time intervals exist
between onset of symptoms of endometriosis and formal diagnosis given that the model
suggests that diagnostic delay results from conceptual beliefs about one’s symptoms;
behavioral factors such as strategies for self-appraisal; and techniques for coping with
illness and emotional reaction (Walter et al., 2012).
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Recommendations for Practice
The findings from this study highlight the importance of earlier diagnosis of
endometriosis opposed to later diagnosis of endometriosis in order to potentially prevent
issues with infertility. For example, the data has shown that a statistically significant
association exists between infertility and the age in which a woman is diagnosed with
endometriosis, with infertility being more frequent among those aged 35 years at time of
endometriosis diagnosis opposed to those aged 23 years at time of endometriosis
diagnosis. Further, the findings of the study address the implications associated with the
presence of uterine fibroids when paired with diagnosis of endometriosis, as well as
conclusions that can be made in regard to the specific site/location of implantation of
endometriosis when considering the odds of infertility.
Conclusion
Although endometriosis has been well-documented in medical texts for more than
4,000 years and was formally discovered microscopically by Karl von Rokitansky in
1860 (Nezhat, Nezhat, & Nezhat, 2012), the disease remains the subject of debate –
especially over the last decade (Brosens & Benagiano, 2011). Furthermore, although
laparoscopic procedure was introduced in the early 1960s, which stands successful in
distinguishing three different clinical presentations of endometriosis (i.e. peritoneal, deep
adenomyotic, and cystic ovarian) (Brosens & Benagiano, 2011), diagnosis of
endometriosis still is found to be delayed anywhere from 7-10 years and is poorly
recognized by physicians in practice, often leading to misdiagnosis and/or suboptimal
care (Johnston et al., 2015).
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Although there is reason to believe that an optimal approach to managing
infertility requires a method associated with routine and timely measures, investigation
concerning causes of female infertility is increasingly receiving less attention (Bell,
2014). With that said, this study aimed to determine whether earlier diagnosis of
endometriosis (e.g. diagnosis at an earlier age) could be considered as a preventative
strategy towards infertility. Although currently existing literature suggests that
suppressive medical treatment of endometriosis does not benefit fertility, the potential
importance concerning the age of women when diagnosed with the disease never has
been taken into consideration (American Society for Reproductive Medicine, 2012;
Radhika et al., 2016) before this study.
This study examined the association between infertility and the age in which a
woman is diagnosed with endometriosis when the covariates, uterine fibroids and
site/location of implantation of endometrioma, are taken into consideration. The findings
from this quantitative study add support to the idea that delayed diagnosis (or diagnosis at
a later age opposed to a younger age) is associated with higher frequency of infertility;
further supporting claims that earlier diagnoses could be considered as preventative
strategies against infertility. Since addressing the gap in the literature, this study has
provided important information related to delayed diagnosis of endometriosis and how
such delays in diagnoses are associated with higher incidence of infertility, with a
statistically significant association existing between infertility and the age in which a
woman is diagnosed with endometriosis after controlling for the presence of uterine
fibroids among the study population. Findings from this study demonstrate and support
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the importance of managing infertility by eradicating the delay that exists in regard to
endometriosis diagnoses.
In conclusion, applying attention to this research study is critical to the
elimination regarding the contribution endometriosis has on the fate of young women
potentially being faced with infertility issues. Given the findings of this study, it is
evident that endometriosis can be eliminated as the number one cause of infertility in
women if the delay in diagnosis of the disease, which currently exists, is eradicated. For
example, if women being diagnosed at age 35 years could be lowered, with more
diagnoses taking place between the ages of 18-25 years, infertility among women aged
18-35 years, specifically, could be reduced significantly; especially given that the results
of this study show a 62% greater odds of facing infertility based on age when diagnosed
with endometriosis, with 20% of infertile participants in the study population being
diagnosed at age 35 years and 0% of infertile participants being diagnosed between the
ages of 18 and 25 years. Given that endometriosis can not be self-diagnosed, it is critical
that physicians in practice aim to better recognize the disease.
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